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ABSTRACT 
At industrial scale, reducing the steps in purification and recovery is desired; this not only 
decreases the cost but also increases the yield. Hydrophobic Interaction Chromatography (HIC) 
and Immobilized Metal Affinity Chromatography (IMAC) are not harsh on biological structure 
or activity of proteins; also both the techniques are economical and therefore a suitable choice at 
industrial level. This dissertation comprises of three parts. The purpose for the Part I was to 
identify and characterize Escherichia coli proteins which display affinity towards both IMAC 
and Hydrophobic Interaction Chromatography (HIC).  Co (II) IMAC was chosen as the primary 
capture step, followed by HIC employing different concentrations of salt to promote adsorption.  
Nine out of the ten proteins identified have iso-electric values less than six, and half are 
considered nonessential.  These data indicated that the combination of IMAC and HIC could be 
developed as a potent method for the purification of recombinant proteins by judicious choice of 
the salt concentration used to promote HIC, the development of E. coli strain(s) deficient in 
certain genomic proteins, and the design of an IMAC - HIC affinity tail for recombinant protein 
isolation based on the very proteins deleted from the genome.  
Part II comprises of study of E. coli Alpha Galactosidase (MelA) as a candidate for affinity tag 
for this dual step purification approach. Affinity of MelA towards Co (II) IMAC and HIC was 
confirmed by fusing with a small peptide.  Metal binding motif and various salt binding motifs of 
MelA were identified and studied. A MelA based affinity tag NT1 was developed by identifying 
the major salt binding region for HIC.   
 
 
   
 
 
It is desirable to have a tag which doesn’t interfere with solubility or biological activity of the 
fused protein. Solubility has been the biggest issue with the development of an affinity tag for 
HIC. In part III, with successful use of novel proteome, we report development of MelA as a 
successful affinity tag for HIC especially as it does not affect the expression, solubility or 
biological activity of the fused protein, with very few co-eluting proteins as contaminants. 
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CHAPTER 1 
 
Background Studies and Literature Review 
 
1.1 Protein Expression and Purification  
A single bacterial cell makes thousands of proteins required for different cellular processes 
during its life cycle. Many proteins are very important from a therapeutic point of view. 
Purification and recovery of these products is one of the most important phases of a bioprocess. 
When dealing with living cells, purification of desired product is all the more challenging (Nfor, 
Ahamed et al. 2008).  In bioprocesses, development of better approaches is always desired for 
the purification of a desired product. With the development of recombinant DNA technology, it 
became easy to produce some of human proteins in E. coli, thus giving controlled and scalable 
ways for protein production (Ferrer-Miralles, Domingo-Espin et al. 2009). Amongst the gram-
negative bacteria, E. coli is the most frequently employed organism for production of 
recombinant products like pharmacological proteins, enzymes and plasmid DNA.   Most of the 
studies have been done in E. coli at genetic and physiology level.  At the industrial level, these 
proteins are produced at a much larger scale and highest recovery and purity of the product is 
essential. A typical bioprocess can be divided in-to upstream and downstream processes. 
Upstream processes deal with expression and production of protein while downstream processes 
are mainly concerned with recovery and purification. Purification of proteins is one of the most 
challenging steps in bioprocesses at industrial level. About 50-60% of the total cost of 
production is spent on downstream processes. Along with the purity, it is essential that these bio-
products retain their biological role. Thus overall economics of an industrial bioprocess depends 
a lot on the purification and recovery steps (Kalyanpur 2002). Research in this field has led to 
   2 
development of better expression and host systems, better mRNA stability, and changes in 
biochemical pathways at genetic level to reduce byproduct production, post translational 
modifications, and decreasing protease activity as a part of strain development (Lesley 2001; 
Mann and Jensen 2003).  Various properties of proteins like molecular size, shape, 
hydrophobicity, solubility, biological activities, and affinity are employed to purify them. 
Economic concerns involved in purification prompts to adopt approaches which can reduce the 
cost involved. Sometimes more purification steps not only increase the cost but also decrease the 
yield due to loss of product at each step of recovery. Various methods like precipitation, 
membrane filtration, centrifugation, etc are used for recovery and purification (Charcosset 1998; 
van Reis and Zydney 2001). A single method is usually not adequate for purification at such a 
large scale, where low cost and purity is desired. This is why more economical and efficient 
approaches have been, for all time, a subject of interest for researchers. But chromatographic 
techniques had come up as a real winner for purification purpose because it exploits different 
biological or physical properties of proteins for separation and we can exhibit high recovery and 
purification as such. 
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          1.2 Immobilized Metal Affinity Chromatography 
IMAC  was introduced by Porath, which is based on the specific property of the proteins 
showing affinity towards chelated metal ions like Co
+2
; Ni
+2 
etc (Porath 1988; Porath 1988; 
Porath 1992).  IMAC has emerged as a major technique for protein purification, in past 20 years 
from research to industrial applications, because of its property of easy scale up for large scale 
application (Gutierrez, del Valle et al. 2007; Vorackova, Suchanova et al. 2011). Different types 
of dentate matrices are used for IMAC but most commonly used are tridentates, e.g 
iminodiacetic acid (IDA) and tetradentates, e.g nitrilotriacetic acid (NTA) due to low cost and 
easy availability (Figure1-1).  
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 Figure 1-1: Commonly used matrices for IMAC 
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IMAC is based on the specific coordinate covalent binding of amino acids, particularly histidine 
to metals ions (Figure 1-2). IMAC is popular technique due to many advantages it possesses. It 
has high protein loading capacities compared to other affinity chromatographies. It doesn’t 
generally affect the structure of proteins and thus does not hinder biological activity. IMAC is 
also used to concentrate diluted proteins. A huge advantage of IMAC is that it can be regenerated 
easily and a charged column can be reused several times.  
 
 
 
 
 
 
 
 
 
 
                    
                    
Sepharose 
 
 
Protein 
              Figure 1-2: Immobilized Metal Affinity Chromatography 
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Though tryptophan and cysteine residues also play a role in metal binding, histidine is the key 
player for IMAC (Hochuli, Dobeli et al. 1987; Miller, Hill et al. 1991). The adsorption of 
proteins is based on the coordination between metal ion and the electron donor group for the 
amino acids like histidine on the surface of proteins. Retention behavior of proteins is largely 
governed by the histidine residues present on the surface. One histidine is enough for weak 
binding for IDA-Cu (II), but more histidine residues in proximity are needed for strong binding 
to Zn (II), Co (II) and Ni (II).  The bound protein is usually eluted by pH gradient or imidazole 
challenge.  
 
Hochuli et al showed that six histidine residues can be tagged to the desired protein and the fused 
protein can be successfully purified using IMAC. Commercial expression vectors are available 
with His6 and His10 tag, so that desired protein can be easily cloned and purified using IMAC 
(Hochuli, Dobeli et al. 1987). Although different vectors with His6 and His10 at C-and N-
terminal are available, His6 at the N-terminal of protein is most common approach for IMAC 
purification. It has been shown by phage-displayed library that His2 also can be used for IMAC 
purification.  It has been shown that isolated SPHHGG-phage fusion eluted with less 
contaminant peptides compared to affinity tails with higher histidine residues (Patwardhan, Goud 
et al. 1997; Mooney, Fredericks et al. 2011). This opens doors for research to look for sequences 
with less number of histidine but appropriate orientation, which can be used for purification with 
more efficient binding and less contaminants. Examples of some of the important proteins which 
have been effectively purified by IMAC are Thrombin, Immunoglobulins, Lysozyme, human  
 
   7 
growth hormone, etc (Aizawa, Winge et al. 2008). His6 tag gives highly efficient purification of 
the fused protein, but one of the disadvantages is that , there are about 15-20 co-eluting proteins 
which show natural affinity towards metals due to surface exposed histidine residues  in their 
structure.  
 
1.3 Hydrophobic Interaction Chromatography 
Hydrophobic Interaction Chromatography was first introduced in 1973 by Hjerten et al (Hjerten 
1973; Hjerten, Rosengren et al. 1974), when they tried to separate proteins on carbohydrate gel 
matrices. Since then with research and development it has been established as a powerful tool for 
protein separation at both research and industrial scale.  Hydrophobic interactions play very 
important role in protein structure and folding and also play important role in biological activity 
like enzyme –substrate reaction, antigen-antibody interaction etc. Most of hydrophobic core is 
usually buried inside the structure but some hydrophobic amino-acids are displayed on the 
surface of the proteins and they are also responsible for hydrophobic binding. HIC separation 
and retention is based on the hydrophobicity of proteins. Hydrophobic regions of proteins are 
generally buried inside the protein structure. In presence of salt buffers, the protein structure 
opens up a little bit, and the buried hydrophobic regions along with the surface exposed regions 
are exposed to the surface (Queiroz, Tomaz et al. 2001; Mahn and Asenjo 2005). During HIC, 
there is a salt promoted hydrophobic interaction between the hydrophobic ligands and the 
hydrophobic regions of proteins (Figure 1-3).  Hydrophobic interactions play an important role in 
proteins resulting in stable and correct folding of proteins. Van der Waal’s forces are main forces 
behind hydrophobic interactions, and the purification is achieved with minimum structural 
damage or de-naturation. Hydropathicity of proteins are dependent on the total of individual 
   8 
hydrophobicity of amino-acids. Hydrophobicity of all amino acids was determined by measuring 
their individual solubility in water and in organic solvents like phenol (Kyte and Doolittle 1982; 
Kyte 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
Different salts like sodium chloride and sodium phosphate are used in the buffer solution to 
promote hydrophobic interactions. There are various theories behind the binding mechanism of 
             Figure 1-3: Hydrophobic Interaction Chromatography 
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protein to HIC column. Use of the salt in the binding buffer during HIC allows opening up the 
protein fold up to some safe level and exposing the hydrophobic region to the column. The 
bound proteins are eluted by either decreasing salt concentration or in absence of salt. The salts 
present in binding buffer increase the free energy associated with protein, when the proteins 
come in contact with hydrophobic stationary phase, and binding to stationary phase decreases the 
surface contact area between the protein and the salt and thus allows little increase in free 
energy.  
The commonly used HIC ligands are linear chain alkanes with or without a terminal amino group 
(Figure 1-4). One of the disadvantages is that sometimes these ligands promote very strong 
interactions with proteins and adsorption is so strong that denaturing conditions or chaotropic 
agents are used for elution. This can denature the biological activity of proteins; in such cases 
ligands with intermediate or mild hydrophobicity are more useful. For this project, we used 
sepharose hydrophobic columns provided by GE Healthcare. HIC is used for purification of 
biomolecules like serum proteins, nuclear proteins etc. Many times HIC is coupled with other 
chromatographic techniques like ion exchange chromatography.  
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Figure 1-4: Commonly used ligands for HIC 
Butyl Alkyl 
Octyl PEG 
Phenyl PPG 
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Development of different stationary phases has increased the use of HIC for separating sensitive 
bio-molecules like proteins and also DNA. HIC being a mild technique does not hinder the 
protein structure and thus maintains its biological activity. HIC with all its advantages is a great 
choice for industrial application for purification. But unlike IMAC there is no affinity tag 
available for easy purification of desired protein using HIC. Like repeated histidines residues are 
to develop metal affinity for IMAC to purify the fused protein, efforts have been done to use 
repeated sequence of hydrophobic amino-acids like tryptophan to work as tag for HIC. But it 
makes the fused protein insoluble and expression of soluble protein is very low.  In this project 
we have tried to look for a sequence from the native proteins of E. coli which can be used to 
develop an affinity tag for purifying desired protein using HIC with no solubility or expression 
issues. 
 
                                                                                                                                                                                         
1.4 Affinity Tags 
Peptide sequences and proteins used to purify other fused proteins are called affinity tags. 
            These tags aid in purification of the proteins lacking affinity towards the particular column 
(Figure 1-5). Some tags aid in purification while some aid in solubility of the desired protein. 
Use of fusion tags has been proved as most effective in improving the expression, solubility. 
Affinity tags have proved to be an efficient tool for purification of proteins independent of their 
biochemical characteristics. With high affinity towards ligand and suitable immobilized supports 
available, small affinity tag sequences allow  
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           proficient purification of fused protein (Waugh 2005; Arnau, Lauritzen et al. 2006; Becker, Van 
Alstine et al. 2008; Li 2010). 
 
Use of affinity tag is one of the most revolutionary discoveries for protein purification. His6 tag 
is one of most widely used tag for one step purification of desired fused protein using IMAC. 
Various fusion tags are available nowadays which employ different modes of interaction with the 
resins and buffers, like Glutathione S Transferase (GST) (Smith and Johnson 1988; Frangioni 
and Neel 1993) and Maltose binding protein (MBP) (Diguan, Li et al. 1988; Maina, Riggs et al. 
1988)
 
which increase the yield and solubility of recombinant proteins, such tags are called 
solubility tags (Table1-1). After purification these tags can be easily cleaved by various proteases 
available e.g thrombin, Factor Xa etc.  
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    Gene 
Gene fusion 
Express   fusion protein 
Fuse DNA encoding ‘tag’ (3’ or 5’) 
Fused protein with  
affinity tag 
Purify fusion protein using 
affinity chromatography 
Desired protein  
Cleave tag from protein if 
required 
Affinity tag 
          Figure 1-5:  Protein purification using affinity tag 
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Tags Size Uses Capacity 
His tag 6 or 8 amino acid Purification 5-14mg/ml 
FLAG 8 amino acid Purification 0.6mg/ml 
GST 211 amino acid Purification and 
solubility 
10mg/ml 
MBP 396 amino acid Purification and 
solubility 
3mg/ml 
Calmodulin binding  
domain 
26 amino acid Purification 2mg/ml 
Strep II 8 amino acid Purification 50-100nmol/ml 
 
 
 
 For IMAC poly histidine tags are most commonly used and it can bind with dissociation 
constant of 10
-5
 to 10
-7
 but there is no successful tag available for HIC till today. Also, there is no 
affinity tag developed for combined use for Co (II) IMAC and HIC together as method of 
purification. In this project, we intend to develop a set of affinity tags by using proteome 
information, for application for HIC individually and combination of HIC and IMAC. 
 
 
 
 
 
 
 
          Table 1 -1: Commonly used tags for purification and solubility 
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PART I 
 
CHAPTER 2 
Identification and Characterization of native proteins of E.coli BL-21 that display affinity 
towards Immobilized Metal Affinity Chromatography and Hydrophobic Interaction 
Chromatography Matrices 
 
 
2.1 Introduction 
In bioprocess development, design of purification strategies has always been an area of intense 
study as it requires new and better approaches.  Understanding the proteome of the cell can aid in 
the design for both laboratory and industrial applications. Knowledge of target and undesired 
protein gives logical tactic to develop methods for better protein purification.  The term 
proteomics refers to a protein level analysis of gene and cellular function in order to better 
understand the biochemistry of organisms (Lyddiatt and O'Sullivan 1998; Cai, Moore et al. 
2004).  It may be extended to the analysis of bioprocessing steps in order to gain insight that may 
be exploited for process improvement.  In this study, we report on the major proteins associated 
with the eluting contaminant pool (ECP) when Immobilized Metal Affinity Chromatography and 
Hydrophobic Interaction Chromatography are operated in a series configuration.  IMAC is one of 
the most popular techniques for purification of proteins, exploiting the metal binding property of 
certain amino acids, in particular histidine, at conditions of high sodium chloride concentration 
(Gaberc-Porekar and Menart 2001; Zatloukalova and Kucerova 2004).  Using IMAC as an initial 
capture step is commonly employed in bio-separations when the protein has native metal binding 
ability or has been endowed with this property via addition of an affinity tail including N- or C- 
terminal extensions with six histidine residues (His6). There has been a desire to pair IMAC with 
techniques that exploit the hydrophobic nature of protein. HIC exploits non-polar group 
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interaction under conditions of high salt concentration.  Both IMAC and HIC are tolerant of a 
variety of compatible salts, hence the complementary nature of the two. 
 
It was hypothesized that combining IMAC with HIC would display a small set of adsorbed 
contaminants that are responsible for both a reduction in column capacity and product specific 
gradient design.  An ECP is defined as proteins which bind and elute under typical operating 
conditions.  Knowledge concerning this protein set can lend insight into new schemes of 
bioprocessing due to a priori information regarding the contaminant pool and how it may impact 
choices related to purification.  In addition to traditional methods of proper salt choice and 
combination to minimize ECP adsorption, one can exploit novel methods that include knockout 
or mutation of certain genes responsible for their expression in order to encounter a smaller ECP, 
and finally, design of an appropriate affinity tail based on ECP adsorption to shift recovery 
towards areas of the gradient with few contaminants. The latter, viz. design of a host strain with 
accompanying affinity tag permits a new avenue that is a direct result of the combination of 
molecular biology and proteomics.  Figure 2-1 describes a basic strategy to combine both strain 
development and affinity tag design by exploiting knowledge of the ECP.  Cell lysate, in this 
case soluble proteins from Escherichia coli, is passed through an IMAC column which is 
developed by reduction in pH, addition of imidazole, or other appropriate method to generate an 
ECP associated solely with IMAC.  After mobile phase adjustment, this pool is then fed to a HIC 
column, and the final protein pool that elutes from the HIC column is subjected to proteome 
analysis.  After proteins in the final ECP are identified, an assessment based either on available 
literature or growth data defines a subset which may be deleted from the genome for strain 
improvement, or altered so they are not captured during the first recovery step.  The concept of 
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gene knockout / modification to provide a minimal contaminant pool has been reported on 
previously (Liu, Bartlow et al. 2009).  A further extension of this concept would be to use 
proteome-based information in the development of affinity tag(s) based on the ECP.  In 
principle, an entire ECP protein or a portion thereof could be used as an affinity tail.  When fused 
to a recombinant target protein, this protein, originally in the ECP but now absent from the 
genome by prior knockout, directs purification.  This results in exploiting binding properties for 
a priori design of the affinity tail.  A complete optimization of an IMAC - HIC system would 
thus incorporate modification to the genome accompanied by a plasmid expression system 
incorporating an ECP protein affinity tag.  We report on the initial stages of developing an 
IMAC - HIC affinity system, focusing on proteins found in the ECP that display useful 
properties (especially Alpha galactosidase).  
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             Figure 2-1:  Overall strategy to improve bioprocesses using proteome analysis 
 
 
 
   Lysate 
       TCP (IMAC)        TCP (IMAC/HIC) 
Identification of                              
Contaminants 
       Essentiality 
Non- Essential 
proteins, 
Deletion 
Strain 
Improvements 
Affinity motif for 
IMAC+HIC based on 
property of deleted 
contaminants 
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2.2    Materials and Methods 
2.2.1   Strain, culture growth and cell lysate  
A single colony of  E .coli BL21 grown on Luria Bertani (Sigma, St. Louis MO) agar plates was 
used to inoculate 5 ml of primary culture and grown at 37 ºC temperature overnight.  Next day, a 
100 ml secondary culture was inoculated with the primary culture and grown at 37 ºC until it 
reached an O.D. of 1-2 measured at 600 nm. The secondary culture was used to inoculate a 
fermenter containing 1.5 liters of Luria Bertani broth, and the culture was grown at 37 ºC with 
sufficient agitation to remain saturated with oxygen.  After 24 hours of growth, the cell pellet 
was recovered by centrifugation at 18,600 g for 15 minutes.  The cell pellet was suspended 10 ml 
of phosphate buffer (0.05 M phosphate, 0.25 M NaCl, pH 7.2), with addition of 100 µl protease 
inhibitor (Sigma, St Louis, MO).  The cell lysate was prepared via four repeated cycles of 
sonication followed by freezing at -20 ºC.  To prepare the final extract for chromatography, the 
cell suspension was again centrifuged for 24,200 g for 10 minutes to remove cell debris. The 
supernatant was collected and the sample was stored in -20 ºC for further analysis. 
 
2.2.2   Protein assay 
The quantification of a protein sample was done by spectrophotometry using a Detergent 
Compatible (DC) assay (BioRad, Hercules CA) which is a colorimetric based, Lowry assay.  The 
absorbance at 750 nm of a protein sample mixed with dye was determined using DU-640 
spectrophotometer (Beckman, Fullerton CA) and compared to the adsorption of a series of 
bovine serum albumin samples. 
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2.2.3    Immobilized Metal Affinity Chromatography 
 A 5-ml column (HisTrap HP IMAC column, Amersham Biosciences) was charged with 5 
column volume (CV) of CoCl2.6H2O (25 mg/ml)   using an AKTA FPLC system (GE 
Healthcare, Piscataway NJ).  The IMAC column was washed with 5 CV of distilled water after 
metal ion charging.  During IMAC, the binding buffer (A) contained 1 M NaCl and 0.05 M 
Na2HPO4 (pH 7.4), while the elution buffer (B) had lower pH (5.5).  Prior to sample loading, the 
column was washed and equilibrated with 5 CV of binding buffer.  Flow rate was 0.5 ml per 
minute.  Elution was monitored at 280 nm with the integrated UV monitor.  After the proteins 
were loaded, non-binding proteins were flushed from the column with 2 CV of wash buffer.  
Finally, washing the IMAC column with 4 CV of the low pH, elution buffer generated an 
intermediate pool of genomic proteins that was loaded to the HIC column. 
 
2.2.4   Hydrophobic Interaction Chromatography   
The protein sample eluted during IMAC was applied to a 1-ml HiTrap Octyl FF HIC Column 
(GE Healthcare, Piscataway, NJ).  All buffers contained 0.02 M Na2HPO4 to maintain the pH at 
7.4.  Three different mobile phase (A) Na2SO4 concentrations were tested (0.25 M, 0.50 M, and 
1M) to investigate the effect on protein adsorption, requiring an appropriate amount of Na2SO4 
added to the injected sample to match the composition of the HIC mobile phase.  Elution buffer 
(B) contained zero concentration of Na2SO4; absence of this salt weakened hydrophobic 
interaction(s) and caused proteins to elute. 
 
After one of the three Na2SO4concentrations was chosen, an experiment consisted of applying 
protein sample, binding and washing the column with buffer containing the chosen Na2SO4 
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concentration, and eluting the protein sample (final ECP).  The HIC column was washed and 
equilibrated with 5 CV of binding buffer (A).  Samples were applied to a HIC column at 0.5 ml 
per minute.  After the non-binding proteins passed during the initial washing with (A), the 
column was developed with a step change in elution buffer (B).  This final pool of protein 
displaying affinity towards IMAC and HIC will be referred to as the final ECP when the results 
are discussed. 
 
2.2.5   2-D electrophoresis and mass spectrometry  
The final ECP protein pool was subjected to 2- dimensional gel electrophoresis (2DGE) followed 
by mass spectroscopy to identify proteins.  Isoelectric focusing was performed with an IPGphor 
instrument (GE Healthcare), using a 7 cm IPG strip and accompanying reagents.  The protein 
pool was desalted using 2D clean up kit (GE Healthcare) and was then applied to an IPG strip 
(pH 3-10) in total volume of 200 μl (62.5 μg protein in 75 μl + 125 μl of rehydration buffer from 
GE Healthcare). The sample was allowed to absorb on strip for 15 minutes, and then covered 
with mineral oil.  After a seventeen hour rehydration period, focusing occurred at these 
conditions: 150 V, 30 mins. 500 V, 30 mins. 1200 V, 40 mins, and 5000 V, 60mins.  A strip was 
then immersed in 10 ml of SDS equilibration buffer (2% (v/v) SDS, 50 mM Tris pH 8, 6M urea, 
30% (v/v) glycerol, and 0.002% bromophenol blue) containing 100 mg of DTT for 15 minutes.  
Finally, the strips were soaked in 10 ml of SDS equilibration buffer with 250 mg of 
Iodoacetamide for 15 minutes.  The second dimension was resolved via electrophoresis using 
12.5% SDS PAGE (Protean II, Bio-Rad).  Proteins were visualized using Coomassie blue.  Spots 
corresponding to the proteins of high concentration were excised and identified by mass 
spectrometry by the Mass Spectrometry and Proteomics Facility at The Ohio State University. 
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2.3   Results 
Table 2-1 describes a portion of the protein pool that had the dual property of Co(II) IMAC and 
HIC retention, i.e. the final ECP.  Under the conditions chosen for the IMAC capture step, about 
13 % of the lysate bound and subsequently eluted from the column due to the step reduction in 
pH.  When this intermediate pool was delivered and eluted from the HIC column, very little 
protein was collected in the ECP.  Indeed, the amount of protein in the final ECP ranged from 
about 6% down to 2 % (based on original mass of proteins in the E. coli lysate), and was 
dependent on the concentration of Na2SO4 used to promote adsorption.   
 
Sample Concentration in sample 
(mg/ml) 
Total protein (mg/ml) Percentage of lysate 
bound 
Lysate 5.2 52 ----- 
IMAC elution peak 0.47 7.5 +/-  2.19 13 
ECP final (high salt) 0.30 3+/- 0.73 5.7 
ECP final (medium salt) 0.16 1.6 +/- 0.57 3.0 
ECP final (low salt) 0.12 1.2 +/- 0.22 2.3 
 
 
                                    Table 2-1: Summary of Chromatography 
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SDS polyacrylamide gels were run to examine the molecular weight distribution and number of 
proteins present in high concentration, recognizing that adsorption via HIC as a function of 
Na2SO4 addition (Figure 2-2).  Qualitatively, decreasing the amount of salt used to promote 
adsorption caused less protein to bind, with lower molecular weight products less favored when 
less Na2SO4 was present. For example, several of the bands representing protein with molecular 
weights less than 50 kDa substantially decreased in intensity or disappeared.   Other proteins in 
minor quantity moved out of the final ECP pool as the salt concentration was lowered.  Referring 
to Figure 2-2, one rather large molecular weight species with molecular weight of 72 kDa 
became absent from the final ECP as Na2SO4 decreased from 0.5 M to 0.25 M , and four proteins 
in large concentration appeared to bind regardless of salt concentration.  Forming additional 
qualitative comparisons could have been made but were not necessarily instructive.  Since the 
point of the experiments were to identify some of the proteins in the final ECP present in high 
concentration with changing adsorption characteristics, a partial analysis would provide the 
needed data to continue the work. 
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1        2        3        4 
100 kD 
50 kD 
 
20 kD 
75 kD 
Figure 2-2:  1D SDS PAGE of final ECP for different Na2SO4 concentrations during 
column loading 
Lanes: 1, IMAC/HIC elutant at 1 M Na2SO4salt concentration; 
2, IMAC/HIC elutant at 0.25 M Na2SO4; 3, IMAC/HIC elutant at 0.5 M Na2SO4 ; 
4, Invitrogen Bench Marker protein ladder 
   25 
To further characterize the final ECP, 2DGE was carried out to separate the proteins based on 
molecular weight and isoelectric point.  Figure 2-2 shows the results obtained with 1.0 M 
Na2SO4, which represented the inclusive set of proteins regardless of salt concentration. Figure 
2-3 and Figure and 2-4 shows the results for lower salt concentration during HIC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                  
 
 
                               
 
 
Figure 2-2:  2D SDS PAGE of final ECP from 1.0 M Na2SO4 
 1 2 
3 
4 
6 
5 
7 
 9 
8 
10 
              1                                2          
50 kD 
20 kD 
Lanes: 1, IMAC/HIC elutant at 1 M Na2SO4 salt concentration; 2, Invitrogen Bench 
Marker protein ladder 
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Lanes: 1, Invitrogen Bench Marker protein ladder; 2, IMAC/HIC elutant at 0.5 M Na2SO4salt 
concentration 
Figure 2-3:  2D SDS PAGE of final ECP from 0.5 M 
Na2SO4 
1                                        2 
50 kD 
20 kD 
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Figure 2-4:  2D SDS PAGE of final ECP from 0.25 M 
Na2SO4 
Lanes: 1, Invitrogen Bench Marker protein ladder; 2, IMAC/HIC elutant  
at 0.25 M Na2SO4salt concentration 
1                                        2 
20 kD 
50 kD 
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Approximately 18 strong bands were evident, with a subset (Table 2-2) representative of the 
three salt conditions identified by pI and MW on separate 2D gels.  Ten of the eighteen proteins 
were identified (Table 2-2).  All proteins are acidic, and fall within the pI range 5.1 - 6.3, with 
the requisite property for IMAC retention, i.e. histidine present on the surface of the protein 
either by inference or crystal structure.  For example, the enzyme transketolase I (Tkt1) has the 
largest number of histidine residues (Litlechild, Turner et al. 1995) , while the enzyme 
triosephosphate isomerase (Tpi) has three which have been confirmed to be surface exposed 
(Noble, Zeelen et al. 1993).  Proteins (gene products of Tkt1, Pyk1, MelA, GatD, and Tpi) in the 
mixture have been identified as nonessential based on categories defined by Gerdes et al 
(Gerdes, Scholle et al. 2003).  The nonessential pool includes, in addition to the previously 
mentioned enzymes, enzymes involved in processes principally coupled to energetics.  Pyruvate 
kinase (Pyk1), a key enzyme in glycolysis as it converts phosphoenol pyruvate to pyruvate, was 
accompanied by alpha galactosidase (MelA), a catabolic enzyme used in the conversion of 
mellibiose into glucose and galactose; and galactitol-1-phosphate-5 dehydrogenase (GatD), an 
enzyme responsible for galactitol degradation (Lengeler 1975; Liljestrom and Liljestrom 1987; 
Mattevi, Valentini et al. 1995; Sauer and Eikmanns 2005). 
 
 
  
2
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Presence in final ECP 
 Swiss-Prot   (E)ssential or   (Na2SO4 in loading step)    MW  
protein (gene) ID pI hydropathicity (N)ot essential 1.0 M 500 mM 250 mM    (kD) 
Alanyl-tRNA  
     synthetase (SyA) P00957 5.53 -0.303 E  √  √ √ 96.0 
Catalase (CatA) P13029 5.14 -0.372 E  √  √ √ 80.0  
2-Dehydro-3’deoxyphophate 
     aldolase (KdsA) P0A715 6.32 -0.028 E  √                30.83 
Lysyl-tRNA 
     synthetase (Syk2) P0A8N5 5.10 -0.399 E  √  √ √           57.82 
Aerobic respiration 
     control protein (ArcA) P0A9Q1 5.21 -0.487 E  √                27.29 
Triosephosphate 
     isomerase (Tpi) P0A858 5.64 0.010 N  √  √              26.97 
Pyruvate kinase (Pyk1) P0AD62 5.77 -0.082 N  √  √              50.72 
Alpha galactosidase (MelA) P06720 5.52 -0.182 N  √  √ √           50.65 
Galactitol-1-phosphate- 
     5 dehydrogenase (GatD) P0A9S3 5.94 0.139 N  √                37.39 
Transketolase I (Tkt1) P27302 5.43 -0.228 N  √  √              72.21 
 
 
 
                                                         Table 2-2: Identification of representative proteins in the final ECP 
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Proteins in the final ECP that were categorized as essential include alanyl-tRNA synthetase 
(SyA), lysyl- tRNA synthetase (Syk2), catalase (CatA), 2-dehydro-3’deoxyphosphate aldolase 
(KdsA), and aerobic respiration control protein (ArcA).  The first two belong to the class II 
aminoacyl-tRNA synthetase family since they possess a conserved ATP binding motif.  Catalase 
(CatA) and aerobic respiration control protein (ArcA) are involved in stress response, with the 
former involved with oxygen toxicity and the latter involved with repression of aerobic enzymes 
when E. coli is starved of oxygen.  The last enzyme (2-dehydro-3’deoxyphosphate aldolase) is 
involved in lipid biosynthesis in gram negative bacteria (Triggsraine, Doble et al. 1988; Miller, 
Hill et al. 1991; Onesti, Miller et al. 1995; Carpena, Melik-Adamyan et al. 2004). 
 
2.4   Discussion 
Previous studies have demonstrated that separately, IMAC and HIC are effective methods to 
resolve protein mixtures.  One of the major appeals of IMAC is that a specific protein can be 
isolated based on metal affinity, whereas HIC is more generic since overall hydropathicity 
dictates adsorption.  There are, obviously, limitations to both techniques in that impurities still 
remain bound to a column, requiring multiple steps in the purification process.  In general, by 
first using a combination of chromatography methods to isolate contaminants followed by 
proteome analysis, a better understanding of the genomic proteins encountered may be obtained 
that ultimately may lead to a simpler, generic purification regiment.  Such a strategy was 
employed to understand the combination of IMAC and HIC.  Data on the protein set is in 
agreement with prior studies with regard to the IMAC capture step, since it has been shown that 
as little as two histidine residues in an appropriate conformation will promote binding to Co (II) 
IMAC columns.  Similarly, data on HIC retention is typically correlated to a negative 
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hydropathicity value.  Hydropathicity of a peptide or a protein is calculated by dividing the 
summation of hydropathy values for all amino acids by the number of the residues in the 
sequence.  Online tools for calculating hydropathicity are available 
(http://www.expasy.ch/tools/protparam.html).  With the exception of the GatD gene product, all 
have negative values or very close to neutral (zero). As the concentration used to promote HIC 
adsorption was decreased from 1 M to 250 mM, fewer proteins were retained.  The very general 
strategy of pH reduction (IMAC) and step change by salt depletion (HIC) was capable of 
providing a small final ECP without the addition of imidazole or gradient design.  This supplied 
a small pool that, while in principle may be further decreased with optimization, provided a 
reasonable starting set of proteins that display the dual property of IMAC and HIC adsorption. 
 
While the data on the final ECP appears to be descriptive in nature, it points toward a future 
direction to develop an IMAC - HIC purification system that exploits both an optimized host 
strain and bioseparation regimen.  Deletion of nonessential gene products will further reduce the 
total number of proteins that carry through the system.  Of course, deletions must be made 
judiciously, because although the enzyme may be deemed nonessential, it may be required from 
a practical standpoint.  A good example is triosephosphate isomerase; databases such as PEC, 
biocyc, and Gerdes et al. defines this enzyme as nonessential because technically E. coli is able 
to survive with an incomplete EMP pathway but growth is severely compromised.  Within the 
confines of such, characteristics of a finalized strain would include (i) sufficient growth 
properties such that it is a viable option for bioprocessing, (ii) the ability to effectively express a 
recombinant product with yields similar to that of established strains, and (iii) limited antibiotic 
scarring (detritus antibiotic resistance genes that are no longer required for selection).  For 
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example, while inactivation of Tpi and Pyk1 through homologous recombination would 
presumably aid in downstream processing, it would compromise growth since their gene 
products are involved heavily in the conversion of glucose to energy and precursors for 
biosynthesis. Modification of these proteins so they are not captured during IMAC via the 
deletion of surface exposed histidine and reintroduction of the mutant into genome via 
recombination would be a more effective strategy for important proteins, as their metabolic 
function would be retained and they would not carry through the bioseparation steps.  In contrast, 
deletion of genes responsible for unnecessary enzymes like MelA and GatD, for example, do not 
affect glucose catabolism and likely would not be deleterious to growth and / or recombinant 
protein expression.  Indeed, experiments with a MelA
-
 mutant displayed growth characteristics 
similar to E. coli MG1655 when glucose was used as the sole carbon source (Fry, Zhu et al. 
2000) .   
 
Germane to the IMAC - HIC system, data on the final ECP will be used to pick an appropriate 
fusion partner (affinity tail) used to endow a target protein with the dual ability of IMAC and 
HIC retention.  Glutathione-S-transferase, maltose binding domain, cellulose-binding domain, 
thioredoxin, and NusA are past examples of fusion partners (proteins) or functional domains that 
have been used in the past to dictate purification using affinity resins.  Results of this study 
demonstrated that alpha galactosidase or galactitol-1-phosphate-5 dehydrogenase could serve in 
a similar fashion as fusion partners for an IMAC - HIC process.  While inactivation of MelA or 
GatD at the chromosomal level removes the protein from an ECP, at the same time constructing 
an expression vector that employs one of these two genes in an appropriate frame can extend 
either the N- or C- terminus of a target recombinant protein in order to force retention.  The 
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MelA gene product is encountered with all three Na2SO4 concentrations, indicating that the 
extension of a recombinant protein with alpha galactosidase could guide elution toward salt 
concentrations that have fewer genomic proteins (e.g. 250 mM).  The smaller protein, galactitol-
1-phosphate-5 dehydrogenase, was found to bind at 1.0 M salt but disappeared as the salt 
concentration decreased.  Two extremes are thus represented by the data, for the GatD gene 
product being a 37 kDa protein can serve as a smaller, good candidate for development of a 
fusion tag with lower salt elution requirements, while the MelA gene product is present in more 
stringent washes but is obviously larger.  Truncated versions of each protein could, in effect, 
dictate binding and lead to a shorter affinity motif. 
 
As fusion partners for a combined IMAC - HIC process, neither alpha galactosidase nor 
galactitol-1-phosphate-5 dehydrogenase currently requires modification because of the native 
binding properties.  This hypothesis can be examined by creating a fusion of alpha galactosidase 
or galactitol-1-phosphate-5 dehydrogenase with a model target like Green Fluorescent Protein.  
Alternately, using predictive tools it may be possible to identify a domain in either protein that 
dominates HIC retention, the more elusive adsorptive properties of the two.  Such identification 
could ultimately result in a smaller fusion tail, and should a HIC domain be identified and tested 
that accidentally abolishes IMAC retention, His6 or a similar sequence can be added back to 
reestablish retention by the primary capture step.   
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PART II 
CHAPTER 3 
Study of Expression and Hydrophobic properties of Alpha galactosidase from E. coli, as 
related to the development of novel affinity sequences for Bioseparation 
 
3.1 Introduction  
The rather large field of protein purification involves many different challenges and as such, new 
approaches to achieve yield and purity are always desired. These approaches include the 
groundbreaking use of affinity tags to dictate adsorption in chromatographic systems, and the 
application of other novel methods to improve upon this strategy of highly efficient [affinity 
based] bioseparation.  Traditionally, the development of affinity tags has been based on 
fundamental biophysical principles.  For example, the addition of short, histidine rich peptides 
serves to promote pi bonding during salt promoted adsorption (Immobilized Metal Affinity 
Chromatography, IMAC); the use of arginine, or other highly charged sequences forces charge – 
charge interaction (ion exchange chromatography); and the inclusion of functional domains or 
portions thereof cause binding via known biospecific interactions (protein A).  Additionally, the 
discovery of other, less intuitive affinity tags has occurred through the use of combinatorial 
libraries and / or phage-display (Patwardhan, Goud et al. 1997; Mooney, Fredericks et al. 2011) . 
The latter includes the identification of candidate peptides for use in antibody purification and 
enzymes, sometimes with surprising results as portions of the phage coat sometime complicates 
interpretation. 
 
Adding to this repertoire of techniques is the use of proteomics to aid the design of candidate 
affinity tags by first determining protein(s) that interact with a particular chromatography matrix.  
   35 
In this fashion, the design of the tag is not constrained by a priori choices like length or amino 
acid composition.  Rather, proteins with certain binding or elution characteristics are identified 
and used to guide choices as the affinity tag is developed. In part I of this project, we have 
identified native Escherichia coli proteins that bind both Co (II) IMAC and HIC during salt 
promoted adsorption.  IMAC and HIC individually are two commonly used techniques; the 
combination of the two recently was proposed for improved purification of recombinant proteins.  
IMAC and HIC are based on totally different fundamentals when it comes to the binding 
properties of proteins.  Metal binding capacity has been found associated mainly with surface 
exposed histidine and cysteines in some cases. Alternately, favorable hydrophobic interaction 
involves adsorption via hydrophobic patches.  Thus, proteins showing affinity towards both 
IMAC and HIC have dual but different properties, presumably decreasing the number of co 
eluting contaminants.  Alpha galactosidase (MelA) was identified as one of the major binding 
proteins during the IMAC / HIC study previously mentioned, and chosen as a protein of interest 
as it was capable of HIC adsorption even at very low Na2SO4 concentrations.   MelA hydrolyses 
mellibiose into glucose and galactosidase in E. coli and is described as one of the nonessential 
proteins for cell survival.  An analysis of the protein revealed that both hydrophobic and 
hydrophilic regions are somewhat balanced with mild dominance of hydrophobic regions.  This 
work represents an effort to study MelA within the context of developing a dual IMAC / HIC 
affinity tail.  We report on the use of different portions of this protein as a fusion partner with 
FLAG to identify sequences useful for HIC in particular, and comment on the suitability of these 
sequences as affinity tags. 
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3.1.1 Alpha Galactosidase (MelA) 
The alpha galactosidase (E.C.3.2.1.22) are the hydrolases which breakdown the sugar molecules 
in smaller subunits. MelA gene encodes for the melibiase (α- galactosidase) which hydrolyses 
mellibiose into glucose and galactosidase (Figure 3-1). The sequence consists of 451 amino acids 
in E. coli with molecular weight of 50.6 kDa as determined on the SDS gel (Liljestrom and 
Liljestrom 1987). The hydropathic analysis of the gene reveals that both hydrophobic and 
hydrophilic regions are present with average hydropathcity of -0.18, showing presence of both 
hydrophobic and hydrophilic regions.  The isoelectric point of MelA is 5.5. Crystal Structure of 
E.coli MelA has not been reported till now. 
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                  Figure 3-1:  Flow chart of Alpha galactosidase (MelA) enzyme action 
 
 
 
     MelB GPH transpoter 
    Melibiose 
Alpha galactosidase: MelA 
                 3.2 .1.22 
β -D- glucose β –D- galactosidase 
Glucose and glucose-1-  
phosphate degradation 
UDP-galactose biosynthesis (salvage 
pathway from galactose using UDP-
glucose) 
   38 
 
There are various scales developed to study the polarity of proteins based upon the individual 
amino acid hydropathicity.  The Kyte- Dolittle scale is one of the most widely used methods to 
determine hydropathicity of proteins. This method is based on the amino acid partitioning 
between two immiscible liquids, water and phenol. As seen in Table 3-1, amino acids with 
negative values of hydropathicity index are non-polar amino acids; with positive value are polar 
amino acids. The protein regions with value above 0 are considered hydrophobic regions. 
Hydrophobic regions of proteins are mostly buried inside of the protein structure. 
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Amino acid residues Hydropathicity 
based on Kyte –Dolittle scale 
    Side chain Polarity 
Isoleucine(Ile) 4.5 Non-polar 
Valine(Val) 4.2 Non-polar 
Leucine(Leu) 3.8 N Non-polar 
Phenylalanine(Phe) 2.8 Non-polar 
Cysteine(Cys) 2.5     Polar 
Methionine(Met) 1.9 Non-polar 
Alanine(Ala) 1.8 Non-polar 
Glycine(Gly) -0.4 Non-polar 
Threonine(Thr) -0.7     Polar 
Tryptophan(Trp) -0.9 Non-polar 
Serine(Ser) -0.8                  Polar 
Tyrosine(Tyr) -1.3                 Polar 
Proline(Pro) -1.3 Non-polar 
Histidine(His) -1.6 Polar 
Glutamic Acid(Glu) -3.2 Polar 
Glutamine(Gln) -3.5 Polar 
Aspartic Acid(Asp) -3.5 Polar 
Asparagine((Asn) -3.5 Polar 
Lysine(Lys) -3.9 Polar 
Arginine(Arg) -4.5 Polar 
 
          Table 3.1: Hydrophobicity of all amino acids based on Kyte-Dolittle scale 
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As seen in Figure 3-2, when MelA sequence was plotted by Kyte – Dolittle method using 
window size of 19, which makes the hydrophobic region stand out, we found 2 major 
hydrophobic regions. The regions between amino acid 9-94 and 342-451 were cloned and 
studied to design a HIC affinity tag. 
 
 
                
 
 
 
 
 
 
Figure 3-2: Kyte Dolittle plot of Alpha galactosidase (MelA) amino acid 
sequence 
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3.1.2 Glutathione –S – Transferase (GST) 
Glutathione –S-Transferase (GST) was chosen as a one of the model protein. Glutathione –S-
Transferases are set of proteins present in both prokaryotes and eukaryotes, and catalyzes variety 
of reactions in cytosol, mitochondria and microsomes. GST catalyzes conjugation of reduced 
glutathione through sulfhydryl group. The protein detoxifies endogenous compounds like 
xenobiotics, toxins, etc. This enzyme protects cell against the carcinogenic and toxic compounds. 
In mammals, GST is especially found in liver cells which plays role in detoxification. GST is a 
very well-studied protein and many other proteins are fused to GST for affinity purification. GST 
is known to increase solubility of the fused proteins. Also due to its glutathione affinity, it’s easy 
to purify using GST columns. The desired proteins are easily expressed and purified by fusing it 
with GST and the fusion protein is purified using GST columns. GST was used as control protein 
in this study. GST with 220 amino acids sequence length and molecular weight of 26kD, has 
been fused with vectors for expression and purification purposes. Ability to check enzyme 
activity, high solubility and lack of retention to HIC and IMAC under given condition prompted 
to select GST as the control protein for this study. Plasmid pGEX-6P-2 provides cloning site to 
fuse protein on C-terminal of GST. We have fused different versions of developed tags from 
MelA on C-terminal of GST, to study its expression and ability to work as affinity tag. 
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   Figure 3-3:  Overview of GST structure and substrate binding: 
Crystal Structure of a Bacterial Glutathione Transferase from E. coli with 
Glutathione Sulfonate in the Active Site 
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3.1.3 Green Fluorescent Protein (GFP) 
Green Fluorescent protein is a protein of 238 amino acid residues with molecular weight of 
approximately 27 kD. It exhibits bright green fluorescence when exposed to ultraviolet light. 
GFP was first isolated from the jelly fish Aequorea Victoria in 1994. Noble prize in 2008 was 
awarded based on GFP discovery and development since its invention it has been widely studied 
for use as a marker due to its easy detection. Today GFP is not only used for bacterial studies but 
also in higher organisms like mice, fish etc. This is because it is easy to fuse protein of interest 
with GFP and we can see the fused protein and also track where it goes in the cell. Here is this 
project, GFP is also used as the control protein, though it binds to HIC column (octyl FF) at high 
salt concentration (1M and 0.5 M), it does not bind to HIC column (phenyl FF) at lower salt 
concentrations (0.5 and 0.25M). We have used GFP containing Plasmid pGPuv from Clontech to 
check N-terminal fusion to GFP of various MelA regions. 
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   Figure 3-4:  Overview of GFP structure  
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3.2 Materials and Methods 
3.2.1 Enzyme digestion, PCR, cleanup and ligation 
Procedures, as described below, require the use of several common molecular biology protocols.  
All enzymatic digestions were carried out using restriction enzymes purchased from New 
England Biolabs (Ipswich, MA) with an appropriate concentration (100 units) in buffer at 37 °C 
for 3 hours.  PCR reactions were performed using Apex Taq DNA polymerase (Genesee 
Scientific, San Deigo,CA)  at 55ºC.  Products from a PCR reaction were examined using 0.8% 
agarose gel.  
   
  
Component  Amount per reaction 
10 X Enzyme Buffer 2 10µl 
pET-22b(M) (100ng/µl)/ PCR product 10µl 
EcoRI (20U/µl) 5µl 
Hind III (20U/µl) 5µl 
Distilled water 20µl 
Total reaction volume 50µl 
            
 
 
 
 
 
 
Table 3-2: Reaction mixture for Hind III / EcoRI restriction digestion 
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Component Amount per 
reaction 
10X Ammonia Buffer 10µl 
dNTP’s(10mM each) 2µl 
Forward primer (10nm/ul) 2.5µl 
Reverse primer (10nm/ul) 2.5µl 
Template 2.5µl 
2.5 mM MgCl2 3µl 
DMS0 5µl 
Gene choice proof reader 
Polymerase 
2µl 
Distilled water 79µl 
Total Reaction Volume 100µl 
 
 
 
 
 
 
 
 
Table 3-3: Reaction mixture for PCR amplification 
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Segment Number of cycles Temperature Duration 
1 1 95 5 minutes 
 
2 
 
30 
95 1.5 minutes 
55 1.5 minutes 
72 1.5 minutes 
 
3 
 
1 
 
72 
 
5 minutes 
 
 
 
 
Component Amount per reaction 
10X T4 DNA ligase buffer 2 µl 
Double digested PCR product 
(100ng/ul) 
8µl 
Double digested pET22(b)M 
(50ng/ul) 
8µl 
T4 DNA ligase  2µl 
Total Reaction Volume 20µl 
 
 Table 3-5: Reaction mixture for ligation  
Table 3-4: PCR amplification cycles 
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3.2.2 Cloning MelA-FLAG in pET-22b (M)   
A cDNA clone for alpha-galactosidase (MelA) was obtained by PCR using genomic DNA 
isolated from E.coli strain BL21 (Table I).  Forward primer P1 and reverse primer P2, matching 
the sequence for MelA (E. coli strain K12 Accession #AAA97019) were designed to include 
NcoI and XhoI sites, respectively.  The reverse primer also included a two amino acid linker 
coding for serine-alanine (SA) and FLAG (DYKDDDDK).  As an intermediate step leading to 
the final clone, the resulting PCR fragment and pET-28b were cleaved with the aforementioned 
enzymes, band purified, and ligated.  This intermediate plasmid was used to generate a plasmid 
based on a modified version of pET-22b. Plasmid pET-22b and pET-22b(M) differed by removal 
of the NdeI – NcoI fragment constituting the DNA sequence of the N-terminal 22 amino acids 
translated from pET-22b. The restricted plasmid was blunted with Mung Bean Nuclease (New 
England Biolabs) and religated. 
 
The plasmid used to express MelA-FLAG was constructed by first isolating the MelA-FLAG 
fusion gene via PCR.  Forward and reverse primers were designed to recapture this sequence 
from the intermediate plasmid, and to extend the gene with flanking sequences for eventual 
restriction with EcoRI and HindIII.  Plasmid pET-22b(M) was cut with EcoRI and HindIII, and 
ligated with PCR product recovered via band purification and restricted with the same two 
enzymes.  Positive clones were selected using PCR selection (Figure 3-7). Final sequence for 
pET-22b(M)MelA-FLAG was determined by DNA sequencing (Molecular Resource Laboratory, 
University of Arkansas for Medical Sciences, Little Rock).  The purified cloned plasmid was 
purified from overnight culture and transformed into chemical competent BL-21 cells.  
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                     Figure 3-5:  Cloning of pET-22b (M) MelA-FLAG 
 
                    E.coli DNA 
 PCR with primers P1 and P2 
 
PCR product and pET-22b digested with Xho1 and Nco1, 
and joined together by ligation 
 PCR product (MELA-FLAG) with Xho1 and Nco1 sites 
 
PCR with primers P3 and P4 
 
 PCR product (MELA-FLAG) with EcoR1 and Hind III sites 
 
PCR product and pET-22b (M) FLAG digested 
with EcoR1 and Hind III, and joined together by 
ligation 
   50 
 
 
 
 
                       
 
 
             
 
 
     
Lanes: 1, NEB 1Kb DNA ladder; 2, MelA FLAG PCR pdt (1.4 kb) 
Figure 3-6: 0.8% agarose gel of PCR for amplification of MelA FLAG 
PCR product. 
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1     2      3     4      5       6      7 
Figure 3-7: 0.8% agarose gel for PCR for selecting positive clones 
containing MelA FLAG segment 
Lanes: 1, NEB 1Kb DNA ladder; 2, 3&5, negative results with absence of 
appropriate PCR pdt; 4, 6&7, positive results with presence of PCR pdt at 1.4 kb 
 
1.6Kb 
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3.2.3 Cloning NT1-FLAG in pET-22b (M) 
 
The hydrophobic regions of MelA were identified using a Kyte-Doolittle plot, with two of the 
major hydrophobic sequences cloned in pET-22b(M) vector using SOE (splicing by overlap 
extension).  The first PCR was done to amplify the DNA region corresponding to amino acids 9 - 
94 by using forward primer P5 and reverse primer P6.  Plasmid pET22b (M)MelA-FLAG served 
as the cloning template. The second PCR used primer P7, reverse primer P8, and pET-22b 
(M)MelA-FLAG as template to amplify the region corresponding to amino acids 342 - 451.  
Next, PCR #3 was done using forward primer P5, reverse primer P8, and purified product from 
the first two rounds of PCR.  For the third PCR, a sequence was chosen that corresponded to a 
thirteen amino acid, hydrophilic sequence, designed to serve as common overlap and linker, 
respectively.  The purified PCR product from the final PCR round was restricted with Hind III 
and EcoR1 and ligated into a similarly restricted pET-22b (M). After chemical transformation 
into competent BL-21, a selected clone was confirmed by DNA sequencing. 
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MAMSAPKITFIGAGSTIFVKNILGDVFHREALKTAHIALMDIDPTRLEESHIVVRKLMDSAGASGKITCHTQQK 
EALQDADFVVVAFQIGGYEPCTVTDFEVCKRHGLEQTIADTLGPGGIMRALRTIPHLWQICEDMTEVCPDATM 
LNYVNPMAMNTWAMYARYPHIKQVGLCHSVQGTAEELARDLNIDPATLRYRCAGINHMAFYLELERKTADG 
SYVNLYPELLAAHDAGQAPKPNIHGNTRCQNIVRYEMFKKLGYFVTESSEHFAEYTPWFIKPGREDLIERYKVP 
LDEYPKRCVEQLANWHKELEEYKNASRIDIKPSREYASTIMNAIWTGEPSVIYGNVRNDGLIDNLPQGCCVEVA 
CLVDANGIQPTKVGTLPSHLAALMQTNINVQTLLTEAILTENRDRVYHAAMMDPHTAAVLGIDEIYALVDDLIA 
AHGDWLPGWLHRSA 
 
 
                                             
                                                       
                                                           + 
        
                                                            DYKDDDK (FLAG TAG) 
 
         
 
 
MAMSAPKITFIGAGSTIFVKNILGDVFHREALKTAHIALMDIDPTRLEESHIVVRKLMDSAGASGKITCHTQQKEAL
QDADFHLWQICEDMTEVCCCVEVACLVDANGIQPTKVGTLPSHLAALMQTNINVQTLLTEAILTENRDRVYHAA
MMDPHTAAVLGIDEIYALVDDLIAAHGDWLPGWLHRSADYKDDDDK 
                      
 
Amino acids 9-94 Amino acids 342-451 Amino acids130-143 
MelA sequence 
Molecular Cloning 
NT 1 sequence 
Figure 3-8:    Scheme for designing NT1 from MelA 
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                   Figure 3-9: Cloning of pET-22b (M) NT1FLAG using Splicing Overlap  
                                                Extension (SOE)   PCR 
 
 
                    pET-22b (M)MelAFLAG 
 
PCR #1 with primers P5 and 
P6 
PCR#2 with primers P7 and P8 
PCR product#1 with common hydrophilic linker PCR product# 2 with common hydrophilic 
linker 
PCR#3 with primers P5 and P8, 
using SOE product1 & product 2 
as template 
PCR product#3(NT1FLAG) with HindIII and EcoR1 sites  
PCR Pdt #3 and pET-22b (M) 
digested with Hind III and 
EcoR1, and joined together by 
ligation. 
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Figure 3-10: Amplification of PCR pdt at 500 b.p detected by 
0.8% agarose gel for SOE PCR #1 and PCR #2 
Lanes: 1&3, NEB 100 bp DNA ladder; 2, SOE PCR pdt #1; 4, SOE PCR pdt #2 
   1                   2                        3                  4 
500bp 
   56 
 
 
 
 
 
 
                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11: Amplification of PCR pdt detected at 800 bp by 0.8% 
agarose gel for SOE PCR # 3 for amplification of NT1-FLAG 
Lanes: 1, NEB 1Kb DNA ladder; 2, SOE PCR pdt #3   
        1                           2 
1.0 Kb 
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Figure 3-12: Amplification of PCR pdt at 800b.p 0.8% agarose gel 
for PCR for selecting positive clones containing NT1 FLAG 
segment 
Lanes: 1, NEB 1Kb DNA ladder; 2,&4, negative results with absence of 
appropriate sized PCR pdt;3,5,6,7,8,9,&10, positive results with  presence of PCR 
pdt  
 
  1    2     3    4     5   6    7    8    9     10 
1.0 Kb 
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3.2.4 Cloning NT1 –GFP in pGFPuv 
The plasmid used to express NT1-GFP was constructed by first isolating the NT1 via PCR.  
Forward P9 and reverse primers P10 respectively were designed to recapture this sequence from 
the NT1-FLAG-pET22b(M) and to extend the gene with flanking sequences for eventual 
restriction with HindIII and SmaI.  Plasmid pGFPuv was cut with HindIII and SmaI, and ligated 
with PCR product recovered via band purification and restricted with the same two enzymes.  
Positive clones were selected using PCR selection. Final sequence for pGFPuv-NT1-GFP was 
determined by DNA sequencing (Molecular Resource Laboratory, University of Arkansas for 
Medical Sciences, Little Rock).  The purified cloned plasmid was purified from overnight culture 
and transformed into chemical competent BL-21 cells.  
 
3.2.5 Cloning of NTB-GFP in pGFPuv 
One of the hydrophobic patches of MelA between amino acid regions 342-451 termed NTB was 
cloned with GFP.  The plasmid used to express NTB-GFP was constructed by first isolating the 
NTB via PCR.  Forward P11 and reverse primers P10 were designed to recapture this sequence 
from the intermediate plasmid, and to extend the gene with flanking sequences for eventual 
restriction with HindIII and SmaI.  Plasmid pGFPuv was cut with HindIII and SmaI, and ligated 
with PCR product recovered via band purification and restricted with the same two enzymes.  
Positive clones were selected using PCR selection. Final sequence for pGFPuv-NTB-GFP was 
determined by DNA sequencing (Molecular Resource Laboratory, University of Arkansas for 
Medical Sciences, Little Rock).  The purified cloned plasmid was purified from overnight culture 
and transformed into chemical competent BL-21 cells.  
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3.2.6 Cloning of GST-NTB in pGEX-6P-2 
The plasmid used to express GST-NTB was constructed by first isolating the NTB via PCR.  
Forward P12 and reverse primer P13 were designed to recapture this sequence from the pGFPuv-
NTB-GFP, and to extend the gene with flanking sequences for eventual restriction with BamH1 
and EcoRI. Plasmid pGEX-6P-2 was cut with BamH1 and EcoRI, and ligated with PCR product 
recovered via band purification and restricted with the same two enzymes.  Positive clones were 
selected using PCR selection. Final sequence for pGEX-6P-2-GST-NTB was determined by 
DNA sequencing (Molecular Resource Laboratory, University of Arkansas for Medical Sciences, 
Little Rock).  The purified cloned plasmid was purified from overnight culture and transformed 
into chemical competent BL-21 cells.  
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Digestion with Chymotrypsin and 
Endopeptidase GluC 
 Soluble fraction of digested 
protein subjected to HIC 
Chromatography 
Elution of bound soluble 
peptides 
Identification of peptides 
binding to HIC 
Mass Spectrometry and Bio-Informatics 
Figure 3-13: Scheme for identifying small soluble peptides from MelA with 
HIC binding property 
       Purified MelA 
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3.2.7 Cloning of GST-RBNT in pGEX-6P-2 
RBNT is 13 amino acid long sequence from MelA, which was identified as one of the peptides 
binding to HIC after protease digestion. The amino acid sequence of RBNT –
(EPCTVTDFEVCKRHGL) was changed to (EPHTVTDFEVHKRHGL) to eliminate the 
cysteines, was fused to GST using pGEX-6P-2 vector. Forward and reverse primers P14 and P15 
respectively were designed to recapture the GST sequence from the pGEX-6P-2 plasmid, and to 
extend the gene with flanking sequences for RBNT sequence and the restriction sites of BstB1 
and EcoR1.  Plasmid pGex-6P-2 was cut with EcoR1 and BstB1, and ligated with PCR product 
recovered via band purification and restricted with the same two enzymes.  Positive clones were 
selected using PCR selection. Final sequence for pGEX-6P-2-GST-RBNT was determined by 
DNA sequencing (Molecular Resource Laboratory, University of Arkansas for Medical Sciences, 
Little Rock).  The purified cloned plasmid was purified from overnight culture and transformed 
into chemical competent BL-21 cells.  
 
3.2.8 Cloning of GST-HIC mini in pGEX-6P-2 
HIC mini is 9 amino acid long sequence from MelA, which was identified as one of the peptides 
binding to HIC after protease digestion. The amino acid sequence of HIC mini –(S V I Y G N V 
R N), was fused to GST using pGEX-6P-2 vector. Forward and reverse primers P14 and P16 
respectively were designed to recapture the GST sequence from the pGEX-6P-2 plasmid, and to 
extend the gene with flanking sequences for HIC mini and the restriction sites of BstB1 and 
EcoR1.  Plasmid pGex-6P-2 was cut with EcoR1 and BstB1, and ligated with PCR product 
recovered via band purification and restricted with the same two enzymes.  Positive clones were 
selected using PCR selection. Final sequence for pGEX-6P-2-GST-HICmini was determined by 
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DNA sequencing (Molecular Resource Laboratory, University of Arkansas for Medical Sciences, 
Little Rock).  The purified cloned plasmid was purified from overnight culture and transformed 
into chemical competent BL-21 cells. 
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Primer 
                       
                                                       Sequence (5'     3’) 
  
P1          
P2        
P3        
P4        
P5         
P6 
P7 
P8 
P9 
P10 
 
P11 
 
P12 
 
P13 
 
P14 
 
P15 
 
 
P16 
 
GACCATGGCAATGTCTGCACCCAAAATTACATTTATCGGC 
GCTCGAGCTTGTCATCGTCGTCCTTGTAGTCAGCGCTACGGTGCAACCAGCCTGG 
CGAATTCATGGCAATGTCTGCACCCAAAATTACATTTATC 
CGA AGCTTCTACTTGTCATCGTCGTCCTTGTAGTCAGC 
TAATACGACTCACTATAGGG 
ACAAACTTCAGTCATATCTTCACAAATTTGCCAAAGATGTTCATAACCGCCAATCTGAAATGC 
CATCTTTGGCAAATTTGTGAAGATATGACTGAAGTTTGTTGTTGCGTAGAAGTAGCCTGTCTG 
GCTAGTTATTGCTCAGCGG 
 
GCCAAGCTTGTCTGCACCCAAAATTTCT 
 
TAATAAATAAATTATAATCCCGGGCGTCAGCGCTACGGTG 
 
GCCAAAGCTTGTGTTGCGTGGAAGTAGCCTGTCTG 
 
AGGATCCTGTTGCGTGGAAGTAGCCTGTCTG 
 
TATACCCGGGATGATGATGGTCAGCGCTACGGTG 
 
AGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAAACA 
 
AATGAATTCCTTATAAACCATGTCTTTTATGAACTTCAAAATCAGTAACAGTATGAGGTTCTG 
GGGATCCCAGGGGCCCCTGGAACAG 
 
AATGAATTCCTTAATTACGAACATTACCATAAATAACACTAGGGGATCCCAGGGGCCCCTGG
AACAGAACTTCCAG 
 
 
 
 
 
 
 
 
Table 3-6: Primers used in study 
   64 
3.2.9 Culture growth and lysate preparation 
A single colony of  E .coli BL21, harboring either cloned plasmid and grown on Luria Berteni 
(LB, Sigma Chemicals, St. Louis MO) agar plates was used to inoculate 5ml of primary culture.  
After overnight growth, 500ml LB broth with ampicillin (100 µg/ml) was inoculated with the 
primary culture and grown at 37 ºC until it reached an O.D. of 0.4 - 0.6, measured at 600nm.  
Cultures were induced using 0.5mM IPTG for expression and grown at 37 ºC overnight with 
sufficient agitation to remain saturated with air.  After 18 hours, cells were obtained as pellet by 
centrifugation at 10,000 rpm for 30 min (Beckman Model J2-21 M/E).  Cell pellet was 
suspended in 10 mL of phosphate buffer (0.05 M phosphate, 0.25 M NaCl, pH 7.2), with the 
addition of 100 L protease inhibitor (Sigma, St Louis MO). Cells were lysed via four repeated 
cycles of sonication followed by freezing at -20 ºC with addition of 100µl protease inhibitor 
(Sigma, St Louis, MO) for 10 ml of cells lysate in phosphate buffer.  To remove cell debris, the 
final extract for chromatography was prepared by centrifugation at 20,000 rpm for 20 min. The 
supernatant was collected and the sample was stored in -20 ºC for further analysis. The lyaste 
was passed through a membrane filter of 0.2µ pore size before applying to column. 
 
3.2.10   Total Protein Quantification 
 Quantification of total protein concentration of all samples was done spectrophotometrically 
(DU-640 spectrophotometer, Beckman Coulter, Fullerton CA) using DC assay technique (Bio 
Rad, Hercules CA) at 750 nm.  This assay is a colorimetric techniques based on Lowry’s 
method.  Bovine serum albumin was used as standard. 
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3.2.11 Immobilized Metal Affinity Chromatography 
 Multiple rounds of chromatography (n=3) were done using an AKTA FPLC system (GE 
Healthcare, Piscataway NJ).  A 5 ml column (HisTrap HP IMAC column, Amersham 
Biosciences) was charged with 5 column volume (CV) of 25 mg/ml CoCl2.  After charging it 
with metal ion, the IMAC column was washed with 5 CV of distilled water prior to equilibration 
with 5 CV of binding buffer.  During IMAC, the binding buffer contained 1 M NaCl and 0.05 M 
Na2HPO4 (pH 7.4), while the elution buffer had lower pH (5.5).  Flow rate was maintained at 0.5 
ml per minute throughout a run.  Elution was monitored at 280 nm with the integrated UV 
monitor.  After loading a sample, unbound / lightly retained proteins were washed off the column 
with 2 CV of buffer.  Finally, washing the IMAC column with 5 CV of the low pH elution buffer 
generated a pool of binding proteins.  When appropriate, both elution and flow through were 
collected for further analysis. 
 
3.2.12 Hydrophobic Interaction Chromatography 
Protein samples were applied to a 1 ml HiTrap Octyl FF HIC Column (GE Healthcare, 
Piscataway NJ).   In order to match the composition of the mobile phase, Na2SO4 was added to 
the sample before loading.  The binding buffer contained 1M Na2SO4, 0.02 M Na2HPO4 (pH 
7.4).  The HIC column was washed and equilibrated with 5 CV of binding buffer.  A flow rate of 
0.25 ml per minute was maintained throughout the run.  After the non-binding proteins passed 
during the initial washing, the column was developed with a step change in elution buffer (0.025 
M Na2PO4, pH 7.2).  The pool of eluted protein was retained for further analysis, and multiple 
chromatographic runs (n=3) were performed to demonstrate reproducibility. 
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3.2.13 SDS PAGE and Western Blotting  
Protein samples were separated by 12.5% SDS -polyacrylamide gel (SDS-PAGE). Proteins were 
transferred from the gel to nitrocellulose membrane at 100v for seventy minutes.  Membranes 
were incubated with anti-FLAG at 1:4000 dilution, anti-GFP at 1:2000 and anti-GST at 1:2000 
with 0.2% BSA in TBS-tween overnight.  After that, membranes were incubated with secondary 
antibody at 1:10000 dilution for 3 hours with 0.2% BSA in TBS- tween, then developed using 
NTB and BCIP in TBS - Tween.    
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3.3 Results 
3.3.1 Expression and Solubility of MelA and NT1 with FLAG tag 
Both the entire MelA gene product and a novel hydrophobic sequence based on MelA were 
cloned and expressed.  Figures 3-8 and 3-9 describe the strategy by which the entire protein, or 
alternately, the 194 amino acid sequence named NT1 was fused to FLAG.  The plasmids, as 
designed, removed the pelB leader sequence from expressed proteins and placed an antibody- 
identifiable feature on the C-terminus of the amino acid sequences under investigation.  
Expression of either MelA-FLAG or NT1 proceeded in batch cultures, as described in the 
methods section.  Typically, overnight growth produced a culture with a final optical density of 
three – four that served as the source of cell extract.  Lysates of either source (MelA-FLAG, or 
NT1-FLAG) were examined via SDS-PAGE and Western blot to confirm the presence of the 
target product (Figure 3-14& Figure 3-15).  As evident by bands corresponding to the proper 
molecular weights (51.8 kD and 26.7 kD), both products were expressed in soluble extract of cell 
lysates.  
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50 kD 
kDK
D 
50 kD 
       1                2                                                                      3                   4 
                    (a)                            (b)    
Lanes: 1, BioRad Dual Color protein Marker; 2, Cell lysate containing 
MelA-FLAG; 3, Cell lysate containing MelA-FLAG; 4, Invitrogen 
prestained protein Marker 
Figure 3-14: Expression of MelA-FLAG in E.coli BL-21; (a) 12.5% SDS-
Polyacrylamide Gel; (b) Western blotting for Expression of MelA-FLAG 
with anti-FLAG antibody 
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25 KD 
50 kD 
      1         2                                                           3       4 
25 KD 
Lanes: 1, BioRad Dual Color protein Marker; 2, Cell lysate containing NT1-
FLAG; 3, Cell lysate containing NT1-FLAG; 4, Biorad Dual Color protein 
Marker 
Figure 3-15: Expression of NT1-FLAG in E.coli BL-21; (a) 12.5% SDS-
Polyacrylamide Gel; (b) Western blotting for Expression of NT1-FLAG with 
anti-FLAG antibody 
50 kD 
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3.3.2 Expression and Solubility of GST and GFP with different developed HIC tags 
Hydrophobic regions in proteins play major role in expression and solubility of fusion proteins. 
If a fused protein is not expressed in soluble form, it brings lot of extra cost to the purification 
and recovery of the target protein. For an economically successful industrial process it is 
important that expression and solubility of fused protein is good, this not only decreases the steps 
involved in purification but also increase the yield. The biggest problem with hydrophobic tags 
till now has been the solubility of the fused protein. So it was very important to study the effect 
of different developed regions with proteins like GST and GFP and thus study solubility with 
both N and C terminal fusion of tags to the control protein. Both the entire MelA gene product 
and a novel hydrophobic sequence based on MelA were cloned and expressed. Lysates of the 
designed clones with either GST or GFP were examined via SDS-PAGE and Western blot to 
confirm the presence of the target product (Figure3-16&Figure3-17). As evident by bands 
corresponding to the proper molecular weights (NT1-GFP at 51 kDa, NTB-GFP at 37 kDa, GST-
NTB at 37 kDa, GST-HIC mini at 27 kDa, GST-RBNT at 27kDa) products were expressed. 
Expression in soluble fraction of all the fused proteins were compared with expression of GST 
and GFP, to see the effect on the solubility of protein when fused to developed tag. From the 
results it was evident that expression and solubility of GST and GFP were decreased when fused 
with NTB, HIC mini, NT1 and RBNT. But it was found that when entire MelA is fused with 
GST and GFP, solubility of GST is not affected by fusion to MelA. 
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                                     (a)                                                                                     (b) 
 
 
 
 
 
 
 
 
 
 
   1                    2      3     4                                                  5        6                 7       8          
Figure 3-16: Expression of GFP with different developed HIC tags in E.coli 
BL-21; (a) 12.5% SDS-Polyacrylamide Gel; (b) Western blotting for 
Expression of GFP fused clones with anti-GFP antibody 
Lanes: 1&6,Cell lysate containing GFP;2&7,Cell lysate containing NTB-
GFP;3&8, Cell lysate containing NT1-GFP; 4&5, Biorad Dual Color protein 
Marker 
37 KD 37 KD 
50 KD 
25 KD 25 KD 
50 KD 
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                                            (a)                                                              (b) 
 
     
 
 
 
 
 
 
 
 
 
Figure 3-17: Expression of GST with different developed HIC tags in E.coli 
BL-21; (a) 12.5% SDS-Polyacrylamide Gel; (b) Western blotting for 
Expression of GST fused clones with anti-GST antibody 
Lanes: 1,6&16, Biorad Dual Color protein Marker;2&11, Cell lysate containing 
GST-hic mini;4&12,Cell lysate containing GST-RBNT;5&15, Cell lysate 
containing GST;6,9,&10, Cell lysate containing GST-MelA;7,13&14, Cell lysate 
containing GST-NTB  
   1      2      3        4       5       6        7        8       9   10     11    12   13   14   15 16  
25 KD 
37 KD 
50 KD 
75 KD 
25 KD 
50 KD 
75 KD 
37 KD 
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3.3.3 Hydrophobic Interaction Chromatography and Immobilized Metal affinity 
chromatography of MELA-FLAG containing lysate 
After confirming expression, lysates were subjected to chromatography.  With regard to MelA-
FLAG, both immobilized cobalt and octyl ligands were capable of capturing the protein.  Figure 
3-18 shows the elution profile of the IMAC chromatography step.  A rather strong signal in the 
Western blot was associated with the peak that typically eluted from the column during the pH 
gradient.  No signal was associated with any fractions corresponding to unbound / lightly 
retained material, or any portion of the column wash prior to the start of the gradient.  Similarly, 
MelA-FLAG could be consistently retained and subsequently eluted from HIC columns.  These 
characteristics are evident from the absence and presence of Western blot signals associated with 
unbound / lightly retained, and adsorbed material (Figures 3-18). 
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 1        2             3          4            5 
50 kD 
60 kD 
    6        7         
50 kD 
60 kD 
20 kD 
Figure 3-18: Results of IMAC/HIC of MelA-FLAG containing lysate;  
(a) Western blotting results; (b) 12.5% SDS-Polyacrylamide Gel  
Lanes: 1, Cell lysate containing MelA-FLAG; 2,IMAC elutant; 3,HIC elutant; 4, HIC 
flowthrough;5,Invitrogen prestained protein Marker;6,HIC elutant;7,Invitrogen bench 
marker. 
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3.3.4 Hydrophobic Interaction Chromatography and Immobilized Metal affinity 
Chromatography of NT1-FLAG containing lysate 
Results obtained with NT1FLAG indicated that Co (II) IMAC was not able to capture the 
protein, whereas octyl FF could successfully adsorb and release the recombinant protein derived 
from MelA.  Lack of IMAC retention was evident by the presence of a signal associated with the 
flow through / unbound protein (Figures 3-19).  There were no indications of column overload 
because the Western blot analysis confirmed the lack of NT1FLAG in samples representative of 
unbound / lightly retained, column washes, or column development. Also, NT1FLAG bound and 
was subsequently eluted as a single peak from the HIC column. These results were accompanied 
by no indication of NT1-FLAG in samples other than the elution peak. To study the HIC binding 
properties of NT1-FLAG, the elution profile was checked at different salt gradient. As seen in 
Figure 3-20, both western and SDS PAGE showed that NT1-FLAG was not eluted with 50% 
Buffer B, low signal is seen in  50% buffer B, showing strong binding to HIC, but NT1-FlAG 
was eluted when column was washed with 100% buffer( absence of Na2So4 in buffer B).  
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   1        2              3          4           5     
25 kD 
37 kD 
Figure 3-19: Western blot results of IMAC/HIC of   NT1-FLAG containing lysate  
Lanes: 1, Cell lysate containing NT1-FLAG; 2, HIC flowthrough; 3, HIC elutant; 4, 
IMAC elutant; 5, BioRad Dual color Marker 
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 1    2     3     4    5    6     7        8    9 10   11 12 13 14    15   16   17   18   19 20 
   
25 kD 
37 kD 
Lanes: 1,2,11&12,Elution at 100 % buffer B;3,4,13&14Elution at 75% buffer 
B;5&15,wash;6,7,16&17Elution at 50% buffer B;8&18 Flow-through ;9&19 Cell lysate 
containing NT1-FLAG;10&20, BioRad Dual color Marker 
50 kD 
Figure 3-20: Results of   HIC of NT1-FLAG containing lysate; (a) Western blotting 
results; (b) 12.5% SDS-Polyacrylamide Gel  
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3.3.5 Hydrophobic Interaction Chromatography and Immobilized Metal affinity 
chromatography with lysate containing GST 
Control experiment was first carried out to check if GST can be used as a control protein. It was 
important that GST didnot bind to HIC and IMAC in given conditions. As seen in result (Figure 
3-20). GST was found in low concentration at 1 M salt concentration in binding buffer during 
HIC. Most of the GST was found in flow through, and a low signal was seen in peak. When 
tested at salt concentration 0.5 M binding concentration, a strong signal was seen in flow through 
and there was no signal in elution sample. Similarly, GST containing lysate was subjected to Co 
(II) IMAC, and it was found that GST did not bind during IMAC and strong signal was present 
in flow through (Figure 3-20).  So GST was selected as control for testing the MelA ability to 
work as tag for IMAC + HIC. 
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Figure 3-21: Results of   HIC and IMAC of   GST containing lysate, 
 (a) Western blot of HIC with GST containing lysate (b) Western blot of 
IMAC with GST containing lysate 
Lanes: 1, Bio-Rad Dual color Marker ; 2, Cell lysate containing GST ; 3, flow through at 
0.5M salt concentration in binding buffer; 4,  Elutant ; 5, Elutant; 6,Elutant; 7, flow 
through at 0.25 M salt concentration in binding buffer; 8, flow through at 0.25 M salt 
concentration in binding buffer; 9, Elutant; 10, Elutant 
   1       2      3         4      5    6        7        8        9     10      11          12      13      14 
25 kD 
50 kD 
37 kD 
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3.3.6 Hydrophobic Interaction Chromatography with lysate containing NT1-GFP 
Control experiment was first carried out to check if GFP can be used as a control protein. It was 
found that GFP was binding at high and medium salt concentration, but not at the lowest salt 
concentration in binding buffer. It was important that GFT doesn’t bind to HIC and IMAC in 
given conditions. NT1-GFP was subjected to HIC with gradient during elution. As seen in result 
(Figure 3-21) most of NT1-GFP was found when column was washed with 50% buffer B. there 
was no NT1-GFP eluted when column was washed with 75% B and 100% B. Most of the NT1-
GFP was found when eluted with 50% Buffer Ba and not detected in flow through. These results 
indicated that NT1-GFP was not very strongly bound HIC column as in case of NT1-FLAG, 
indicating that folding of NT1-GFP is such that it was not binding to HIC very strongly .  
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75 kD 
50 kD 
25 kD 
37 kD 
Figure 3-22: Results of   HIC of NT1-GFP containing lysate; (a) 12.5% SDS-
Polyacrylamide Gel; (b) Western blotting results 
Lanes: 1&20, BioRad Dual color Marker; 2&19 Cell lysate containing NT1-GFP; 3&18, 
Flowthrough;4,5,16&17,Elution at 50 % buffer B;6&15,wash;7,8,13&14Elution at 75% 
buffer B;9,10,12&11,Elution at 100% buffer B 
 1    2     3      4        5    6   7     8    9   10     11 12 13  14     15   16   17      18   19  20     
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3.3.7 Hydrophobic Interaction Chromatography with lysate containing GST-NTB and 
NTB-GFP 
NTB is the smaller version of NT1 comprising of MelA region between amino acids 342-451. 
GST-NTB was subjected to HIC at 0.25M salt concentration in binding buffer. The expression of 
GST-NTB and NTB-GFP decreases compared to GST and GFP in soluble fraction.  Both fusion 
proteins run approximately at 37 kDa. Figure 3-22 and 3-23 show SDS PAGE result of HIC with 
GST-NTB and NTB-GFP respectively. The elution profile does not show strong presence of 
GST-NTB or NTB-GFP at these conditions on SDS PAGE. 
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Lanes: 1,2,3&4,Elutant;5,6,Wash;7,8,Flowthrough;9,Cell Lysate containing 
GST-NTB;10, Bio-Rad Dual Color protein Marker 
Figure 3-23: 12.5% SDS PAGE results of HIC of GST-NTB containing lysate  
   1       2        3       4         5       6          7        8         9      10 
50 kD 
75 kD 
37 kD 
25 kD 
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   1          2        3           4           5         6         7             8         
Lanes: 1,Cell Lysate containing NTB-GFP;2&3,Elutant;4, Bio-Rad Dual Color protein 
Marker 5,Wash;6,7,Elutant;8,Flowthrough 
Figure 3-24: 12.5% SDS PAGE results of HIC (0.25M salt in binding buffer) 
 of NTB-GFP containing lysate  
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3.3.8 Hydrophobic Interaction Chromatography with lysate containing GST-HIC mini and 
GST-RBNT 
HIC mini NTB is the smaller version of NT1 comprising of MelA region between amino acids 
342-451. GST-NTB was subjected to HIC at 0.25M salt concentration in binding buffer. The 
expression of GST-NTB and NTB-GFP decreases compared to GST and GFP in soluble fraction.  
Both fusion proteins run approximately at 37 kD. Figure 3-22 and 3-23 show SDS PAGE result 
of HIC with GST-NTB and NTB-GFP respectively. The elution profile does not show strong 
presence of GST-NTB or NTB-GFP at these conditions on SDS PAGE. 
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 1           2          3          4            5          6           7            8               
Figure 3-25: 12.5% SDS PAGE results of HIC (0.25M salt in binding buffer)  
of GST-HIC mini containing lysate  
Lanes: 1, BioRad Dual Color Protein Marker; 2, Cell Lysate containing  
GST-HICmini; 3, Flow-through; 4, 5, 6, 7&8, Elutant 
50 kD 
25 kD 
37 kD 
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Figure 3-26: 12.5% SDS PAGE results of HIC (0.25M salt in binding buffer)  
of GST-RBNT containing lysate  
Lanes: 1,2,3,4,5,6,7,Elutant;8,Flowthrough;9,Cell Lysate containing GST-
RBNT;10, Bio-Rad Dual Color protein Marker 
   1       2     3      4       5      6      7     8        9     10 
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3.4 Discussion 
In order to provide a rational design basis for a dual IMAC – HIC affinity tag, the binding 
properties of alpha galactosidase were examined. HIC is used widely at an industrial scale as it 
possess several advantages like mild operating conditions,  does not affect biological activity of 
proteins, its easily scalable, and less expensive compared to other affinity chromatographic 
techniques. But unlike other techniques, there is no affinity tag available for practical use for 
HIC purification due to solubility issues. NT1, the designed tail by combining hydrophobic 
regions of MelA, fused with FLAG was readily able to bind during HIC, and was found in 
soluble fraction as discussed in results. Thus NT1 has emerged as potential candidate for the 
development of first HIC tag that may aid with solubility issues, the subject of our next 
investigation. NT1 fails to bind to IMAC, but IMAC binding can be easily reestablished by 
constructing a   His6NT1 tag. That way the dual affinity property can be retained for an IMAC+ 
HIC purification approach.  
 
Both HIC and IMAC binding characteristics could be explained in term of primary amino acid 
sequences, even in the absence of crystal structure of E.coli MelA. The binding properties of 
NT1-FLAG and analysis of amino acid sequence gave insight into the hydrophobic and metal 
binding domains of MelA. Surface exposed histidines play major roles  in IMAC binding, and 
since metal affinity of MelA was lost in NT1, it was interesting to look at the possible IMAC 
binding sites present in region deleted from the  MelA (between amino acids 95-341) . It was 
found that out of total 15 histidine residues present in MelA, 8 are present in the region which 
was deleted from MelA to design NT1. Also, a metal binding site for MelA which has been 
identified as Cys173 was deleted in designing NT1. These results leads to the conclusion that the 
   89 
possible Co(II) IMAC binding motif of  MelA lies in region between amino acids 95-340 and its 
deletion leads to loss of Co(II)IMAC binding. In conclusion , the combined  hydrophobic 
regions(NT1) recognized in this study are strong candidates for development of the first affinity 
tag for hydrophobic interaction chromatography, and when enhanced with a small IMAC tag like 
His6 will be able to exploit the full binding potential of native MelA.  
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PART III 
CHAPTER 4 
 
Proteome-based development of novel affinity tail for Immobilized 
Metal Affinity Chromatography and Hydrophobic Interaction Chromatography 
 
 
4.1 Introduction 
 Based upon the previous results, we know that Alpha galactosidase is able to bind Co (II) IMAC 
and HIC at all 3 salt concentrations. In this part of the dissertation, we have tested the ability of 
MelA to work as a dual affinity tag to purify the desired protein using Immobilized Metal 
Chromatography (IMAC) and Hydrophobic Interaction Chromatography (HIC) and also for HIC 
by itself. Having identified MelA as a potential tag by fusing it with FLAG tag, in this part of 
work, we have tested MelA fusion with GST (bigger protein) to purify it using HIC + IMAC and 
HIC . Here HIC with 0.25M salt concentration in binding buffer was used as the first step, only 
those proteins with highly hydrophobic regions will be binding at such a low salt concentration 
and Co (II) IMAC was used as the second step. At 0.25M salt concentration during HIC, there 
are very few co-eluting proteins and so a successful HIC tag can also be used alone as a 
purification step, with tailored strain (with gene knock out of the contaminants). This will also 
check the loss of protein by having more than one step purification. 
It is desirable to have a tag which doesn’t interfere with solubility or biological activity of the 
fused protein. Solubility has been the biggest issue with the development of affinity tag for HIC. 
With MelA being a native protein sequence we intend to handle this problem. Here, we have also 
studied effect of MelA fusion to GST solubility and enzyme activity.   
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4.2 Methods and Materials 
4.2.1 Cloning of GST-melA-pGEX-6P-2 
Figure 4.2 shows the scheme of GST- MelA cloning. A cDNA clone for alpha-galactosidase 
(MelA) was obtained by RT-PCR using genomic dna isolated from E.coli strain BL21.  Forward 
primer P17 and reverse primer P18 (Table 4.1) matching the sequences for MelA (E. coli strain 
K12 Accession #AAA97019) were designed to include BamHI and EcoRI sites, respectively. 
The resulting PCR fragment (Figure 4.3) was digested using BamHI and EcoRI and ligated into a 
similarly restricted pGEX-6P-2 (GE Healthcare) to produce the plasmid GST-melA-pGEX-6P-2.   
The clones containing the MelA fragment was screened by doing PCR (Figure 4.4). Final 
sequence was determined by DNA sequencing (Molecular Resource Laboratory, University of 
Arkansas for Medical Sciences, Little Rock).   
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                    E.coli DNA 
 
PCR with primers P1 and P2 
 
 PCR product (MELA) with BamH1 and EcoR1 sites 
 
PCR product and pGEX-6P2 digested with BamH1 
and EcoR1, and joined together by ligation 
         Figure 4.1:  Cloning of pGEX-6p-2- MelA 
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Figure 4-2: 0.8% agarose gel of PCR for amplification of MelA PCR 
product. 
Lanes: 1, NEB 1Kb DNA ladder; 2, MelA PCR pdt (1.4 kb) 
1                       2 
1.5 kb 
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Figure 4-3: 0.8% agarose gel of PCR for amplification of MelA PCR 
product. 
Lanes: 1, NEB 1Kb DNA ladder; 2 -10, MelA PCR pdt (1.4 kb) 
 1      2    3     4    5   6      7    8    9    10                       
1.5 kb 
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4.2.2 Cloning of pGFPuv-MelA-GFP 
A cDNA clone for alpha-galactosidase (MelA) was obtained by RT-PCR using genomic dna 
isolated from E.coli strain BL21.  Forward primer P19 and reverse primer P20 matching the 
sequences for MelA (E. coli strain K12 Accession #AAA97019) were designed to include EcoRI 
and HindIII sites, respectively. The resulting PCR fragment was digested using EcoRI and 
HindIII ligated into a similarly restricted plasmid pGEM-3Z to produce the plasmid MelA in 
pGEM-3Z.   The clones containing the pGEM-3Z- MelA fragment was screened by doing PCR. 
The purified plasmid pGEM-3Z-MelA was double digested with Kpn1 and Hind III and ligated 
to similarly digested plasmid pGFPuv. The resultant plasmid contained MelA-GFP in pGFPuv. 
This plasmid was used as template to amplify MelA-GFP using forward primer P21 and Reverse 
primer P22 with restriction sites Bgl II and HindIII. The amplified pcr product of MelA-GFP was 
double digested using Bgl II and HindIII and ligated in similarly digested plasmid pBAD-myc-
HisA. Final sequence was determined by DNA sequencing (Molecular Resource Laboratory, 
University of Arkansas for Medical Sciences, Little Rock).   
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Primer 
                       
                                                       Sequence (5'     3’) 
  
P17          
P18 
P19 
P20 
P21 
P22 
 
CAGGATCCATGATGTCTGCACCCAAAATTACATTTATCGGC 
 
CGAATTCTTAACGGTGCAACCAGCCTGG 
GGCCGAAGCTTGATGTCTGCACCCAAAATTACATTTATCGGCG 
TGGTACCGCACTTCCGCGGGGTACAAGGTGGTGGTGACGGTGCAACCAGCCTGG 
 
GCAAAGATCTATGTCTGCACCCAAAATTACATTTATCGGC 
 
TGCAAGCTTTTATTTGTAGAGCTCATCCATGCCATGTGTAATC 
 
 
                                           Table 4-1: Primers used in study 
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4.2.3 Culture growth and Lysate preparation 
Single colony of   E .coli BL21 with   plasmids containing inserts were   grown on Luria Berteni 
(Sigma Chemicals, St. Louis MO) agar plates with 100µg/ml of ampicillin and used to inoculate 
5ml of primary culture and grown at 37ºC temperature overnight.  Next day, 500 ml LB broth 
with ampicillin (100µg/ml concentration) was inoculated with the primary culture and grown at 
37ºC until it reached an O.D. of 0.4-0.6, measured at 600nm. 0.5mM IPTG was used to induce 
the expression and the culture was grown at 28ºC with sufficient agitation to remain saturated 
with oxygen overnight.  After 18 hours, O.D of about 2.0 was measured for the culture; cells 
were obtained as pellet by centrifugation at 10,000 rpm for 30 mins (Beckman Model J2-21 
M/E).  The cell pellet was suspended in phosphate buffer (0.05 M phosphate, 0.25 M NaCl, pH 
7.2), with addition of protease inhibitor (Sigma, St Louis,MO,USA). Cells were lysed via four 
repeated cycles of sonication followed by freezing at -20ºC with addition of 100µl protease 
inhibitor (Sigma, St Louis, MO) for 10 ml of cells in phosphate buffer.  To remove cell debris, 
the final extract for chromatography was prepared by high speed centrifugation at 20,000 rpm for 
20 mins. The supernatant was collected and the sample was stored in -20ºC for further analysis. 
The lyaste was passed through a membrane filter of 0.2µ pore size before applying to column. 
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4.2.4 Total Protein Quantification 
 The total protein assay for quantification of all protein samples was done spectrophotometrically 
(DU-640 spectrophotometer, Beckman Coulter, Fullerton CA) using a DC assay (Bio Rad, 
Hercules CA) at 750 n.m. The D.C assay is a colorimetric techniques based on Lowry’s method.  
Bovine serum albumin was used as standard. 
 
4.2.5 GST Activity Test 
GST activity of fusion protein GST-MelA was tested to check the effect of MelA fusion on GST 
enzyme activity. GST assay kit (Sigma, MO, USA) was used for this purpose. This assay is 
based on the principle GST mediated catalysis of conjugation of L- glutathione to CDNB (1-
Chloro-2, 4-dinitrobenzene) through the thiol group of the glutathione.  
 
 
 
 
Conjugation of the thiol group of glutathione to the CDNB substrate causes an increase in the 
absorbance at 340 nm. Rate of increase in the absorbance is directly proportional to the GST 
activity in sample. Cell lysates containing GST was used as positive control, and H2O was used 
to measure blank reading. BL-21 lysate was used as a negative control. All the reactions were 
tested in 1 ml quartz cuvette. Table 4.2 shows the mixture for testing GST activity.  
 
 
 
 
                               
GSH + CDNB                             GS-DNB Conjugate + HCl 
 GST 
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Reagent Volume 
Dulbecco’s Phosphate Buffered Saline 980 µl 
200mM L-Glutathione reduced 10µl 
100mM CDNB 10µl 
 sample 2-20µl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-2:  Reaction mixture for GST activity test 
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4.2.6 Hydrophobic Interaction Chromatography 
The protein sample eluted during IMAC or the cell lysate was applied to a 1-ml HiTrap Octyl FF 
HIC Column (GE Healthcare, Piscataway NJ).   Na2SO4 was added to the sample before loading 
to match the composition of the HIC mobile phase.  The binding buffer was made of 0.25M 
Na2SO4, 0.02 M Na2HPO4 (pH 7.4).  The HIC column was washed and equilibrated with 5 CV of 
binding buffer.  Samples were applied to a HIC column at 0.25 ml per minute and maintained 
throughout the run.  After the non-binding proteins passed during the initial washing, the column 
was developed with a step change in elution buffer (0.025 M Na2PO4, pH 7.2).  The pool of 
protein eluted was used for further analysis like Western blotting and protein quantification or 
loaded to IMAC as the second step. 
 
4.2.5 Immobilized Metal Affinity Chromatography 
A 5-ml column (HisTrap HP IMAC column, Amersham Biosciences) was charged using 5 
column volume (CV) of 25 mg/ml CoCl2 using an AKTA FPLC system (GE Healthcare, 
Piscataway NJ).  The IMAC column was washed with 5 CV of distilled water after charging it 
with cobalt.  During IMAC, the binding buffer contained 1 M NaCl and 0.05 M Na2HPO4 (pH 
7.4), while the elution buffer had lower pH (5.5).  Before sample loading, the column was 
washed and equilibrated with 5 CV of binding buffer.  Flow rate was maintained at 0.5 ml per 
minute throughout the run.  Elution was monitored at 280 nm with the integrated UV monitor.  
After loading the proteins, the unbound proteins were washed off the column with 2 CV of wash 
buffer.  Finally, washing the IMAC column with 5 CV of the low pH, elution buffer generated 
pool of binding proteins that was subjected to western blotting. Both elution and flow through 
were collected for further analysis. 
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4.2.6 SDS PAGE and Western Blotting 
Protein samples were separated by 12.5% SDS -polyacrylamide gel (SDS-PAGE). Proteins were 
transferred from the gel to nitrocellulose membrane at 100volts for seventy minutes.  Membranes 
were incubated with anti-GST (GE Healthcare) at 1:4000 dilution and 1:2000 dilution for Anti-
GFP (Clontech) with 0.2% BSA in TBS-tween overnight.  After that, membranes were incubated 
with secondary antibody at 1:10000 dilution for 3 hours with 0.2% BSA in TBS- tween, then 
developed using NTB and BCIP in TBS - Tween.    
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4.3 Results 
4.3.1 Expression and Solubility of GST-MelA                     
 
                                                           
                 
 
 
 
 
 
                       
 
 
 
       
 
Figure 4-4: Western blot results of expression and solubility of GST and 
GST-MelA  
Lanes: 1, Bio-Rad Dual color marker; 2, total protein fraction of GST; 3, Insoluble 
fraction of GST; 4, Soluble fraction of GST; 5, total protein fraction of GST-MelA; 6, 
Insoluble fraction of GST-MelA; 7, Soluble fraction of GST-MelA; 8, Bio-Rad Dual color 
marker  
   1          2           3         4            5               6               7            8 
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25 kD 
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75 kD 
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Figure 4-5: 12.5% SDS PAGE of expression and solubility of GST-MelA and 
GST  
 1      2            3     4      5            6     7     8 
Lanes: 1, Bio-Rad Dual color marker; 2, uninduced sample; 3, total protein fraction of 
GST; 4, Insoluble fraction of GST; 5, Soluble fraction of GST; 6, total protein fraction of 
GST-MelA; 7, Insoluble fraction of GST-MelA; 8, Soluble fraction of GST-MelA  
75 kD 
25 kD 
GST-MelA 
Degraded 
pdt 
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The expression of GST-MelA was checked for solubility of the fusion protein. As per the 
western blot and SDS PAGE (Figure 4-5 and Figure 4-6), fusion of MelA to GST does not hinder 
its solubility. Solubility and expression are two big issues with the fusion protein. But we found 
that MelA as a tag is not at all interfering with the GST solubility and the expression of GST-
MelA is high in soluble fraction. Both GST and GST-MelA are also present in insoluble fraction, 
due to high expression not all the protein is folded. But from the results it is clear that amount of 
GST present in soluble fraction is similar to the GST-MelA present in soluble fraction showing 
that solubility and expression of GST is not affected by fusion with MelA. But in case of GST-
MelA, some degraded product is also noticed. We have calculated expression of GST and GST-
MelA lysates in total, soluble and insoluble fractions. Densitometry was performed to estimate 
relative protein concentration using ImageJ Software. As per the table below, approximately 
21% of the total protein present in soluble fraction of GST-MelA lysate is GST-MelA (75kD) 
and the degraded product (26 kD). 
Sample    Relative Concentration of GST/Fusion   protein 
in total fraction  
GST Lysate (Total protein ) 22% 
GST Lysate (soluble Fraction) 19.4% 
GST Lysate (Insoluble Fraction) 23.87% 
GST-MelA Lysate (total protein) 17% 
GST-MelA(Soluble Fraction) 21.26 
GST-MelA(Insoluble Fraction) 23% 
 
 
 
Table 4-3: Table for the relative concentration of protein present in soluble, insoluble 
and total fraction of lysates 
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4.3.2 Hydrophobic Interaction Chromatography and Immobilized Metal affinity 
chromatography with lysate containing GST-MelA and MelA-GFP 
Lysate containing GST-MelA was first subjected to HIC (Octly FF) with 0.25M salt 
concentration in binding buffer as the first step. Unlike GST, GST-MelA bound to HIC even at a 
low salt concentration. As seen in Figure 4-7, 4-8 and 4-9, GST-MelA binds to HIC at even the 
lowest salt concentration tested here. Strong signal was observed in HIC elutant and a weak 
signal is seen in the flow-through. The HIC elutant was then subjected to Co (II) IMAC as the 
second step to check its binding. As seen in Figure 4-9, the results of Western blotting, no signal 
was observed in IMAC flow through and strong signals were observed in IMAC elutant.                                       
As seen in Figures, HIC and IMAC samples were loaded to check the total contaminant pool 
(TCP).  Here HIC (0.25M salt concentration in binding buffer) was the first step, and most of the 
proteins were not binding HIC at such a low salt concentration and present in flow through. 
About 6-7 proteins are present in HIC elutant along with GST-MelA. When HIC elutant was 
subjected to IMAC, IMAC elutant shows presence of only two proteins, GST-MelA at 75kD and 
MelA at 50 kD. 
Silver staining was performed to identify proteins present even in low concentrations (Figure 4-
8). 4-5 more proteins are observed in very low concentrations with silver staining which is more 
sensitive than Coomassie staining. To check binding of GST-MelA to less hydrophobic column 
than Octyl FF is Phenyl FF column to check if GST-MelA can bind to it and if contaminant 
proteins can be eliminated by using less hydrophobic column. It was found that as much as 4-5 
proteins were present in HIC elutant. 
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MelA-GFP containing lysate was subjected to HIC to check C terminal fusion of MelA to GFP 
and check its ability to work as a HIC tag. As seen in Figure 4-12, Western blotting results of 
samples from HIC of MelA-GFP at 0.25M salt concentration in binding buffer. MelA-GFP low 
signal was seen in flow-through, but strong signal was observed in MelA-GFP. But when 
compared the recovery and presence of fusion protein in flow-through, it seems that GST-MelA 
is binding with higher affinity and more target protein was recovered. 
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Figure 4-6: Coomassie blue staining of 12.5 %SDS gel of HIC/IMAC with 0.25 
M salt in binding buffer of   GST-MelA containing lysate  
Lanes: 1, Bio-Rad Dual color Marker ; 2, Blank; 3, Cell lysate containing GST-MelA ; 
4, Blank; 5, HIC flow-through; 6, HIC  elutant ; 7, IMAC flow-through  ; 8,IMAC 
flow-through  ; 9, IMAC elutant ; 10, IMAC elutant 
   1       2         3      4       5           6          7       8        9       10 
75kD 
50kD 
GST-MelA 
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  1             2              3      4       5       6        7      8      
Figure 4-7: Silver staining of 12.5 %SDS gel of HIC/IMAC with 0.25 M salt 
 in binding buffer of   GST-MelA containing lysate  
Lanes: 1, Bio-Rad Dual color Marker; 2, Cell lysate containing GST-MelA ; 
 3, HIC flow-through; 4, HIC elutant ; 5, IMAC flow-through  ; 6,IMAC 
 Flow-through; 7, IMAC elutant ; 8, IMAC elutant 
75kD 
50kD 
    GST-MelA 
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    1        2       3        4          5         6             7          8        
Figure 4-8: Western blot results of HIC with 0.25 M salt in binding buffer  
of  GFP- MelA containing lysate  
Lanes: 1, Bio-Rad Dual color Marker; 2, HIC flow through; 3, Cell lysate containing  
MelA-GFP;4&5 HIC elutant; 6,wash;7&8,HIC elutant 
75 kD 
50 kD 
37 kD 
25 kD 
   110 
 
 
 
 
 
 
 
               
                      
 
 
 
 
 
 
 
 
 
Figure 4-9:  12.5 %SDS gel of HIC using Phenyl FF column with 0.25 M salt in binding 
buffer of   GST-MelA containing lysate  
Lanes: 1&14, Bio-Rad Dual color Marker; 2, Cell lysate containing GST-MelA; 
 3, flow-through; 4&5, wash; 6-13, HIC Elutant 
75 kD 
50 kD 
37 kD 
75 kD 
37 kD 
50 kD 
    1        2       3        4         5         6         7       8     9    10     11     12   13                 14 
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Figure 4-10: Western Blotting of HIC with 0.25 M salt in binding buffer of    
GST-MelA containing lysate  
Lanes: 1&4, Bio-Rad Dual color Marker; 2&5, Cell lysate containing GST-MelA; 
3, flow-through; 6&7, HIC flow-through; 8-13, HIC Elutant  
50 kD 
37 kD 
25 kD 
75 kD 
      1                2        3           4       5      6       7       8       9      10      11     12    13   
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Figure 4-11: Western Blotting of HIC with 0.25 M salt 
 in binding buffer of  MelA-GFP containing lysate  
Lanes: 1, Bio-Rad Dual color Marker; 2, Cell lysate containing MelA-GFP; 
 3, flow-through; 4, Wash; 5-10, HIC Elutant 
    1    2       3        4        5       6      7         8       9       10 
50 kD 
25 kD 
37 kD 
75 kD 
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4.3.4 GST Activity Test 
GST activity of samples was tested using the kit as mentioned earlier. Blank, BL-21 lysate, GST 
lysate and GST-MelA lysate were tested. Absorbance at 340 n.m was taken at every 30 seconds. 
The results of absorbance taken are shown below as graph representation, comparing each 
samples are shown in Figure 4-10. 
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Figure 4-12: Graph representation of absorbance at 340 n.m  
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Figure 4-13: Graphical representation of absorbance at 340 n.m of HIC samples 
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Fraction Volume Total 
Protein 
(mg) 
Activity 
(units) 
Total 
Activity 
(units*ml) 
Specific 
activity(units/mg) 
Fold 
Purification 
Lysate 3ml 15.3 2.08 6.24 0.4 1 
Hic Peak 6ml 0.360 1.947 11.4 31.6 79 
Hic 
Flowthrough 
4ml 12.56 -    
 
   
                                         Table 4-4:  Purification Table of GST-MelA  
 
 
 GST specific activity of each sample was calculated. As per the Figure 4-13, the enzyme activity 
of  GST-MelA and GST lysates were tested. It was found that the GST activity is not hindered 
due its fusion to MelA. GST and E.coli BL-21 lysate was similar to the activity of GST lysate 
used as positive control.  These results show that MelA fusion to GST does not affect its 
biological activity, though fusion of GST to NTB, RBNT and HIC mini lost the GST activity. 
Specific activity of the protein load, flow-through and elutant during HIC was calculated. And as 
per Table 4-4, it was found that approximately 80 fold increase in the enzyme activity of the 
purified protein.   
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4.4 Discussion 
From these results, we found that MelA can be used as the affinity tag for both 2 step purification 
combining HIC + IMAC and one step purification using HIC. The most desirable properties for 
an affinity tag are that it does not interfere with the folding of the fused protein and thus in turn 
the solubility and biological activity. Mis-folding of the fused protein makes it insoluble and 
loses its biological activity, especially with HIC this has been a big challenge. Based on our 
results we conclude that MelA when fused with a desired protein can be produced in soluble form 
and most of fused protein was recovered during HIC with very few contaminants. Higher 
specific activity was found in HIC elutant compared to the lysate loaded and the flow-through. 
The enzyme activity of GST is not hindered with the MelA fusion. From the specific activity 
study of the elutant from HIC experiment, it can be concluded that most of the fusion protein 
loaded on HIC was recovered during elution. Many of the affinity tags are required to get 
cleaved from the fused protein to get make it biologically active, but here the purified protein is 
not required to get cleaved if it is not used in vivo. Such a low salt concentration (0.25M 
Na2SO4) in the binding buffer of HIC, leads to elimination of most contaminants and only highly 
hydrophobic proteins regions will absorb. Elution buffer of HIC is compatible with next step i.e 
IMAC so there is no need of buffer exchange step required, reducing the cost and loss of product 
by cutting an extra step for purification. In conclusion, we report MelA as the first tag which can 
be used for purification approach using HIC and IMAC.  
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CHAPTER 5 
 
Conclusions and Recommendations 
 
5.1 Conclusions: 
Here we have developed a bioseparation system comprised of a suite of affinity tags used to 
facilitate purification. We identified E. coli alpha-galactosidase as a protein which, under 
conditions of salt promoted adsorption, binds both Immobilized Metal Affinity Chromatography 
(IMAC) and Hydrophobic Interaction Chromatography (HIC) resins. The entire protein and 
individual domains of the protein have separately been tested as affinity tags based on a 
separation scheme that consists of IMAC + HIC and HIC alone. We have shown that MelA and 
NT1 (tailored MelA) can be successfully used as the affinity tag to purify fused proteins using 
Hydrophobic Interaction Chromatography at very low salt concentration in binding buffer, with 
very few co-eluting proteins, though entire MelA as an affinity tag is more effective in terms of 
recovery of fused protein. The major issues associated with HIC affinity tails i.e expression and 
solubility is solved by using native protein of E.coli as a base for the development of tag. 
Biological activity of fusion partner is maintained with maximum recovery when HIC is used as 
the single step purification with very few co-eluting contaminants.  
Combining affinity tail design based on proteomic data and homologous recombination to alter 
genomic protein expression, within the context of improving bioseparation, has placed this work 
on a path towards creating a novel platform strategy with E. coli. 
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5.2 Recommendations 
 
5.2.1 Development of tailored strain for use of HIC and HIC + IMAC based purification. 
For the essential proteins, which are also the co-eluting proteins, modifications are recommended 
as the future goal so they are not captured during IMAC via the deletion of surface exposed 
histidine, and reintroduction of the mutant into genome via recombination would be a more 
effective strategy for important proteins, as their metabolic function would be retained and they 
would not carry through the bioseparation steps.  In contrast, deletion of genes responsible for 
unnecessary enzymes like MelA and GatD, for example, do not affect glucose catabolism and 
likely would not be deleterious to growth and / or recombinant protein expression.   
5.2.2 Fusion of MelA and NT1 with other proteins to check their ability as affinity tags. 
 
We have used small peptide (FLAG) and larger protein (GST) to fuse with the MelA and checked 
its ability to work as affinity tag. But it is recommended that the developed tag should be fused 
and check with other proteins which do not show affinity to HIC under the given conditions 
naturally.  Such proteins which can act as control should be fused with the tag and tested for 
purification conferred by the tag. 
5.2.3 Comparison of developed tag (MelA and NT1) with other affinity tags. 
 
Though MelA shows binding capacity to HIC and IMAC, IMAC retention can be increased by 
using His6, when IMAC+ HIC to be used as purification approach.  Dissociation constant (Kd) is 
defined as half the concentration of ligand required to occupy half of the binding sites of 
proteins. A smaller dissociation constant value leads to higher affinity towards the ligand. So, 
affinity tags with lower Kd value are desired to have higher binding. Low Kd indicates that less 
concentration of A and is required for formation of complex [AB]. Different affinity tags can be 
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compared for better binding properties for both IMAC and HIC which could be quantitatively 
compared based on their Kd values. 
5.2.4 Use of proteome approach for affinity tag development.  
 
Here we have used a proteome approach to identify and develop affinity tag for HIC and 
successfully solved the problem of expression and solubility for HIC tag. Based on the success of 
a proteomic approach in this work, such knowledge can be used to design tags for other 
chromatographic techniques and other living system such as yeast.  
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APPENDIX 
 
 
Evaluation of Escherichia coli proteins that burden non-affinity-based chromatography as 
a potential strategy for improved purification performance 
 
ABSTRACT 
Escherichia coli is a favored host for rapid, scalable expression of recombinant proteins for 
academic, commercial or therapeutic use. To maximize its economic advantages, however, it 
must be coupled with robust downstream processes. Affinity chromatography methods are 
unrivaled in their selectivity, easily resolving target proteins from crude lysates, but they come 
with a significant cost. Reported in this study are preliminary efforts to integrate downstream 
separation with upstream host design by evaluating co-eluting host proteins that most severely 
burden two different non-affinity based column processes. Phosphoenolpyruvate carboxykinase 
and peptidase D were significant contaminants during serial purification of GFPuv by 
hydrophobic interaction and anion exchange chromatography. Ribosomal protein L25 dominated 
non-target binding of polyarginine-tagged GFPuv on cation exchange resin. Implications for 
genetic knockout or site-directed mutagenesis resulting in diminished column retention are 
discussed for these and other identified contaminants. 
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 Introduction 
 
 
 In recent decades, advances in upstream technologies have dramatically improved cell   culture 
scale, yield, and performance. Recombinant DNA techniques, hybridoma technologies, 
mammalian cell culturing, metabolic engineering, and fermentation improvements have permitted 
large-scale production of biological therapeutics (Langer and Ranck 2006; Nfor, Ahamed et al. 
2008; Tugcu, Roush et al. 2008). A shift has thus occurred, as the manufacturing steps limiting 
productivity are now downstream. Beyond initial product recovery steps, chromatographic 
separation remains the cornerstone in downstream processing of therapeutics in both industry and 
academia. In an effort to quicken time-to-clinic and market, research efforts have focused on 
cutting material costs, improving productivity at large-scale, and developing robust, generic 
separation steps (Shukla, Hubbard et al. 2007; Shukla and Hinckley 2008). Since downstream 
processes account for 50-80% of total manufacturing costs, these efforts to ameliorate purification 
of high-value, high-quality products are critical to success in the biopharmaceutical industry 
(Fahrner, Knudsen et al. 2001; Lightfoot and Moscariello 2004; Roque, Lowe et al. 2004; 
Aldridge 2006). 
 Affinity chromatography media is favored for its superb selectivity, particularly media with 
conjugated proteins for monoclonal antibody capture such as protein A. The remarkable 
performance comes at a cost, however, as protein A resin is over 30 times more expensive than 
typical ion exchange resins (Follman and Fahrner 2004). Although resin lifetime is limited by 
fouling by product or contaminant build-up, loss is primarily due to ligand degradation after 
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repeated cycles of stripping and regeneration (Jiang, Liu et al. 2009). To mitigate costs, 
investigations that seek to find alternatives to packed-bed chromatography are trending upward. 
For example, advanced techniques for bulk separation via aqueous two-phase partitioning, three-
phase partitioning, specific and non-specific precipitation, crystallization as well as use of 
uncharged, charged and affinity-based membranes for filtration and chromatography are of high 
interest to industry (see reviews (Przybycien, Pujar et al. 2004; Thömmes and Etzel 2007; Shukla 
and Thommes 2010)). Follman and Fahrner characterized seven multi-step chromatography 
schemes using non-affinity based media, particularly hydrophobic interaction (HIC), anion (AEX) 
and cation exchange chromatography (CEX), to assess their performance against protein A in the 
purification of Chinese Hamster Ovary-derived monoclonal antibodies (Follman and Fahrner 
2004). Three such processes were found to be comparably effective in removing CHO proteins as 
the more traditional protein A-CEX-AEX process. Effective purification of proteins endowed 
with positively charged polyarginine tails have also been demonstrated. Sassenfeld and Brewer 
pioneered the concept by fusing five consecutive arginines to the C-terminus of recombinant 
human urogastrone (Sassenfeld and Brewer 1984). Variants of a positively charge 58-amino acid 
sequence excised from the B domain of staphylococcal protein A has been successfully used as a 
fusion tag for protein isolation via CEX (Graslund, Lundin et al. 2000; Hedhammar and Hober 
2007). Separation to high purity of cyclodextrin glycosyltransferase fused to polylysine or 
polyarginine has also been reported(Kweon, Lee et al. 2002). 
Use of non-affinity based matrices is favored for their low cost and robustness towards harsh 
cleaning procedures, but lesser selectivity means multiple steps are typically needed to remove 
host contaminants. We seek to improve efficiency in the downstream phase by integrating 
rational host design upstream. This requires focused examination of host proteins that remain 
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bound to column matrix after equilibration, which reduces capacity for the target protein, as well 
as proteins that co-elute with the target itself. Co-eluting proteins are particularly bothersome 
since they reduce final purity and resolving such proteins with similar physicochemical 
properties to the target complicate the process with additional, orthogonal purification 
steps.These drive up operational costs and detriment overall yield. Prior studies by our group and 
collaborators have demonstrated this approach. Identification of contaminating Escherichia coli 
proteins and tailoring of the host cell for improved downstream processing has been applied in 
applications of immobilized metal affinity chromatography (Cai, Moore et al. 2004; Liu, Bartlow 
et al. 2009; Tiwari, Woods et al. 2010; Bartlow, Uechi et al. 2011). Similar work has also 
elucidated proteins that commonly diminish IMAC performance (Bolanos-Garcia and Davies 
2006) . 
Such methodology is the basis of the work presented in this study on non-affinity-based 
matrices. We used a similar approach to improve technical knowledge of host proteins with a 
likelihood of contaminating two schemes base on hydrophobic and electrostatic interaction, HIC-
AEX and polyarginine-aided CEX. Based on the results, preliminary direction for development 
of tailored host strains with intrinsically improved separation performance is discussed.
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Materials and Methods 
Strains, Cell Growth and Medium 
E. coli BL21 (DE3) harboring pGFPuv (Clontech, Palo Alto, CA, USA) was used for both HIC 
and AEX purifications and ammonium sulfate precipitations. BL21 (DE3) expressing GFPuv 
with an N-terminus arg6 tag was used for CEX purification. For cloning arg6-GFP, in pGEM3Z 
as a first step, PCR was carried out using forward and reverse primers and pGFPuv as template. 
Forward primer (5’-ATA AAG CTT CAT GAG TCG TCG TCG TCG TCG TCG TAA AGG 
AGA A-3’) was designed to include HindIII restriction site and six arginine residues. Reverse 
primer (5’-TTG AAT TCA TTA TTT GTA GAG CTC ATC CAT GCC ATG TGT AAT CC-3') 
was designed to include EcoRI restriction site. The resultant PCR fragment was ligated into SmaI 
restricted pGEM3Z, to produce blunt end ligated arg6-GFP-pGEM3Z. The sequence of arg6-
GFP-pGEM3Z was confirmed by the DNA sequencing (Molecular Resource Laboratory, 
University of Arkansas for Medical Sciences, Little Rock, AR). The arg6-GFP fragment was then 
subcloned by digesting arg6-GFP-pGEM3Z and pGFPuv with HindIII and EcoRI, followed by 
ligation to produce arg6-pGFPuv. The sequence of arg6-pGFPuv was again confirmed and 
protein expression was verified by Western blotting and fluorescence determination. 
Overnight cultures in 25 g/L Luria–Bertani (LB), supplemented with 100 ug/mL ampicillin, were 
diluted 1:25 in 500 mL fresh LB in a 2 L flask. Cells were induced with 1 mM IPTG at 2 h when 
A660 was approximately 0.4. Fermentations were carried out in a shaker at 37 °C and 200 rpm for 
7 h until the A660 reached 2.2 – 2.5. Cell pellets were collected by centrifugation at 5000 g for 20 
min at 4 °C and stored at -80 °C prior to lysis. 
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Sample Preparation 
Cell pellets were resuspended in the appropriate chromatography starting buffer and 
supplemented with 0.5% Triton X-100, 0.4 mM MgCl2, 1 mM phenylmethylsulphonyl fluoride 
(PMSF), as well as 0.5 mg/mL lysozyme unless otherwise noted. Contents were stirred with a 
glass rod and incubated on ice for 10 min prior and during sonication at 7 W (RMS) for 15 min 
using a Vibra cell ultrasonifier (Thermo Fisher Scientific, Rockford, IL, USA). Cell debris was 
pelleted at 5000 rpm for 20 min at 4 °C and supernatants were passed through a 0.45 m filter 
prior to column loading. 
 
Purification of non-tagged GFPuv 
All column purifications were performed with an ÄKTAprimePlus purification system with real-
time monitoring of total protein absorbance at 280nm and prepacked columns from GE 
Healthcare (Piscataway, NJ, USA) operating at 1 mL/min and room temperature. Operating 
conditions of AEX and HIC purifications were independently optimized using soluble lysate from 
BL21 (DE3) pGFPuv. For AEX optimization, 1 mL HiTrap Q FF columns (GE Healthcare) were 
readied with five column volumes (CV) of start buffer, five CV of eluting high salt buffer, then 
equilibrated with start buffer again before loading five CV of soluble extract in varying 
conditions. Initially, optimal pH was determined from a series of experiments where extracts were 
prepared as described above using 20 mM Bis Tris starting buffer containing no salt, then pH 
adjusted to either 5.4, 5.7, 6.0, 6.2, 6.7 or 7.2. After loading, columns were equilibrated with start 
buffer until A280 reached baseline before applying a 20 CV eluting gradient from 0 mM to 1 M 
NaCl, followed by five CV of 1 M NaCl before re-equilibration with start buffer. Fractions of one 
CV were collected. Offline, each fraction was assayed for GFPuv fluorescence in triplicate using 
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a Tecan Infinite M200 96-well plate reader with excitation/emission spectra set to 395/509 nm 
with subtraction of background fluorescence of non-GFPuv proteins. Extracts were adjusted to pH 
6.2 for subsequent runs optimize the starting ionic strength. AEX runs using start buffers 
containing 50 or 100 mM NaCl were compared in the same manner. 
For HIC optimization, 1 mL HiTrap Phenyl FF low-sub and high-sub columns were compared, 
as were starting ammonium sulfate concentrations. Extracts were initially prepared in HIC 
elution buffer, 20 mM NaH2PO4, pH 7.2. Then 5 mL samples of which were adjusted with 
elution buffers lacking or containing 4 M (NH4)2SO4 to 8 mL, creating a series of extracts in 
starting buffers ranging from 0.7 to 1.5 M (NH4)2SO4 with equal protein concentrations. After 
spin down of any precipitated material and filtration, 5 mL samples were initially applied to the 
low-sub matrix after washing with five CV eluting buffer (low salt) and equilibration with start 
buffer (high salt). Sample loading was followed by start buffer equilibration to A280 baseline then 
elution with a 15 CV gradient and five CV equilibration with low salt buffer. Columns were 
regenerated with five CV of distilled water followed by five CV of start buffer. This scheme with 
1.5 M (NH4)2SO4 starting buffer was used to evaluate the high-sub matrix. Fractions of one CV 
were collected and assayed as noted above. 
  Final purification for proteomic analysis consisted of initial precipitation, in which clarified 
lysate was adjusted to 1.5 M ammonium sulfate and allowed to incubate on ice for 10 min prior 
to spinning down of precipitated proteins and cell debris (10,000 g, 30 min, 4 °C). Supernatant 
was loaded on low-sub a HIC column and bound proteins were pooled (13 mL), sealed in 
dialysis tubing (MWCO 3500 Da, Fisherbrand, Thermo Fisher Scientific, Waltham, MA, USA), 
and floated in a graduated cylinder containing 1 L AEX start buffer (20 mM Bis Tris, 50 mM 
NaCl, pH 6.2) with gentle stirring. Buffer was refreshed once after several hours. Five mL of this 
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sample was applied to the AEX column using the scheme described above. For comparison, the 
column order was reversed. Five mL of AEX bound proteins were similarly dialyzed overnight 
in 0.5 L HIC eluting buffer. Sample adjustment to 1.5 M (NH4)2SO4 preceded the optimized HIC 
step. 
 
Ammonium Sulfate Precipitation 
A soluble extract containing GFPuv was prepared as above and eight 1-mL aliquots were placed 
in 1.5 mL eppendorf tubes. A stock solution of saturated ammonium sulfate (541.8 g/L, 25 °C) 
was prepared and added to each aliquot to create a series of concentrations from 0.8 – 1.5 M in 
0.1 M increments. Aliquots were incubated on ice for 30 min then spun 30 min at 10,000 g, 4 °C. 
Supernatants were carefully transferred to new tubes without disturbing protein pellets. With 
exception to the 1.5 M aliquot, stock solution was again added according to the formula provided 
by EnCor Biotechnology (Gainesville, FL, USA, http://www.encorbio.com/protocols/AM-
SO4.htm) to achieve final concentrations of 0.9 – 1.5 M ammonium sulfate. Solutions were 
incubated, spun, and separated as before. Pellets were washed with 50 L 20 mM bis-Tris buffer 
(50 mM NaCl, pH 8.5) before final spin down for 15 min at 15,000 g, 4 °C. Resulting pellets 
were resuspended in 3X sample buffer for gel analysis. 
 
Cation Exchange Chromatography of arg6-GFPuv 
 Operating conditions of CEX purifications were determined using soluble extract from BL21 
(DE3) expressing arg6-GFPuv. Extracts were prepared, in this instance, without the use of 
chicken egg lysozyme (pI 11.35, Sigma, St. Louis, MO, USA) as it interfered with target binding 
in initial trials. Column operation and optimization was similar to that of AEX, using 50 mM 
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MES start buffer and extract pHs adjusted to range from 5.5 to 6.0. Five mL of extract was 
applied to HiTrap SP FF columns before start buffer equilibration and NaCl gradient or step 
elutions. Ultimate isolation of proteins was carried out at pH 5.7 with a 15 CV gradient from 0 to 
1 M NaCl. This was immediately followed by a step to 2 M NaCl for ten CV to ensure total 
protein desorption and column regeneration. For comparison, the identical procedure was carried 
out with BL21 (DE3) pGFPuv. 
 
Protein Concentration, Assessment, and SDS-PAGE 
Select fractions were concentrated using Amicon ultrafiltration cartridges with a MWCO of 3 
kDa (Millipore, Bedford, MA, USA). Excessively dilute protein fractions were concentrated by 
trichloroacetic acid/deoxycholate precipitation, dried, and stored at -80 °C. Total protein 
concentrations were determined by the Bio-Rad protein assay using BSA standards (Bio-Rad, 
Hercules, CA, USA). Soluble samples were mixed 1:1 with 3X sample buffer, incubated in a 
water bath for 3 min at 75 °C. Precipitated samples were resuspended in 3X sample buffer and 
incubated in the water bath at least 6 min for adequate solubilization. Samples were loaded into 
NuPAGE 4-12% Bis-Tris gels and run at 120 V for approximately 1.5 h in MOPS running buffer 
(Invitrogen, Carlsbad, CA, USA) Protein bands were visualized with Coomassie G-250 GelCode 
Blue stain reagent (Thermo Fisher). Gels were scanned at 2400 dpi with an Epson Perfection 
4490 photo scanner (Long Beach, CA, USA). Densitometry to estimate relative protein 
concentrations and GFPuv purity was performed with ImageJ software 
(http://rsb.info.nih.gov/ij). Image background was subtracted using the “rolling ball” algorithm 
set at 1200 pixels, or half the image resolution, and the sampling box to acquire the density 
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profile was approximately one-third the lane width, according to Gassmann et al(Gassmann, 
Grenacher et al. 2009). 
 
Peptide Mass Fingerprinting Analysis 
Gel spots of interest were manually picked and digested using the methods of Shevchenko et al 
(Shevchenko, Tomas et al. 2006) with a few modifications. Briefly, plugs were cut from gel 
bands and destained. Reduction and alkylation utilized 2.5 mM tris(2-carboxyethyl) phosphine 
(TCEP) and 3.75 mM iodoacetamide, respectively, in 100 mM ammonium bicarbonate. Plugs 
were reduced during incubation for 15 min at 65 °C in an air thermostat and alkylated as 
instructed. Trypsin Gold (Promega, Madison, WI, USA) was prepared in 25 mM ammonium 
bicarbonate. Tryptic peptides (1 L) were deposited on a MALDI plate, dried, and then 
crystallized with 1 L -cyano-4-hydroxycinnamic acid (CHCA). Spots were washed by 
pipetting down then up 1 L 0.1% formic acid then allowed to dry. MALDI-TOF-MS spectra 
were acquired with an Applied Biosystems Voyager DE Pro (Framingham, MA, USA) with 
delayed ion extraction and reflection mode. Spectra were analyzed using Data Explorer software 
version 4.6 (Applied Biosystems) by setting the signal-to-noise ratio to 5 or higher and filtering 
the mass list for monoisotopic peaks and charge states of one.  All identifications were confirmed 
by searching the SwissProt database (release 2011_02; 525207 sequences; 185522689 residues) 
using Mascot search engine (Matrix Science Inc., Boston, MA, USA).(Perkins, Pappin et al. 
1999) Trypsin was set as the proteolytic enzyme allowing for one missed cleavage, oxidation of 
methionines and carbamidomethyl cysteines selected as variable modifications, and peptide mass 
tolerance set to +/- 0.3 Da or less. 
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Results and Discussion 
Purification of non-tagged GFPuv 
GFPuv was a well-suited choice for a generic model protein not only for convenient assay, but 
its medium size (27 kDa) and acidic isoelectric point (pI 5.7) are reasonably average in the 
context of the host proteome. Ideally, a group of model proteins with a spectrum of net charges 
would be used. The resulting analysis would perhaps generate a more complete list of host 
proteins that contaminate the IEX step across a broader range of binding parameters. This could 
allow design of a host strain with intrinsically better downstream efficiency that is more robust to 
IEX conditions. In light of this idea, process development that established only most 
fundamental conditions for GFPuv purification via HIC and AEX was carried out. We chose this 
approach so these processes, with minimal alteration, could be applicable for purification of a 
wider range of target proteins. Further, by not fully optimizing the binding and eluting conditions 
for GFPuv, the intent was to put less restriction on the likelihood that any identified 
contaminants could appear in similar processes in which a protein of interest is purified. 
Ultimately, however, the overall approach can be applied to cases where a target requires binding 
or eluting conditions that significantly deviate from those reported here. Contaminants relevant 
to that specific process could then be identified. 
Initial experiments on HiTrap Phenyl FF (low-substitution) columns revealed that loading 
soluble lysate adjusted to 1.5 M ammonium sulfate allowed adequate GFP retention and had 
superior resolution than found with high-substitution matrix (data not shown). GFPuv 
breakthrough at the end of the loading phase, measured by the fluorescence exiting the column 
normalized to the cleared lysate, was 6% and 30% with 1.5 M and 1.2 M ammonium sulfate, 
respectively. Further, the elevated concentration resulted in significant precipitation of other 
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strongly expressed proteins, easing binding competition with the target. This is more clearly 
illustrated in Figure 1, which shows sequential “cuts” of an ammonium sulfate precipitation. 
OmpF was identified among those that were preferentially reduced prior to HIC column loading 
(confirmed by PMF; Mascot score 116, e- value 1.3e-6, 9 peptides, 33% sequence coverage). 
Initial trials on Q columns determined that an optimal loading buffer was 20 mM Bis-Tris, 50 
mM NaCl at pH 6.2. While GFPuv retention was comparable at pH 6.0 during trials with soluble 
lysate, peak resolution was slightly advantageous at pH 6.2. With the chosen salt concentration 
and pH, 0.5 units more basic than the target’s pI, GFPuv was present in the first major peak 
following gradient salt elution. Further, GFPuv breakthrough was not detected during column 
loading. 
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Figure -1: Ammonium sulfate precipitation of proteins expressed in BL21 (DE3) 
pGFPuv 
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Purification 
Steps 
Total protein 
(mg) 
GFP (mg) yield Purity Purification 
HIC-AEX 
Soluble extract 
Hitrap Phenyl FF 
Post Dialysis 
Hitrap Q FF 
 
42 
 
29 
 
4.5 
 
2.4 
 
8.6 
 
8.0 
 
1.9 
 
1.6 
 
100 
 
92 
 
-- 
 
84 
 
21 
 
27 
 
42 
 
66 
 
1 
 
1.3 
 
2.0 
 
3.2 
CEX 
Soluble extract 
Hitrap SP FF 
 
47 
 
13 
 
8.8 
 
7.9 
 
100 
 
90 
 
19 
 
50 
 
1 
 
2.6 
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Table 2: Proteins co-eluting with GFPuv during purification via ammonium sulfate precipitation, HIC, and AEX
Gene Protein Name 
Protein Mass 
(Da) 
Protein pI 
UniProtKB Accession 
No. 
ileS Isoleucyl-tRNA synthetase 104231 5.66 P00956 
acnB Aconitate hydratase 2 93439 5.24 P36683 
pckA Phosphoenolpyruvate carboxykinase 59606 5.46 P22259 
pepD Aminoacyl-histidine dipeptidase 52882 5.20 P15288 
gltA Citrate synthase 47984 6.21 P0ABH7 
sucC Succinyl-CoA ligase [ADP-forming] subunit beta 41367 5.37 P0A836 
gcvT Aminomethyltransferase 40121 5.36 P27248 
talB Transaldolase B 35197 5.11 P0A870 
cysK Cysteine synthase A 34468 5.83 P0ABK5 
tsf Elongation factor Ts 30404 5.22 P0A6P1 
dapD Tetrahydrodipicolinate N-succinyltransferase 29873 5.56 P0A9D8 
gmhA Phosphoheptose isomerase 20802 5.97 P63224 
ahpC Alkyl hydroperoxide reductase subunit C 20748 5.03 P0AE08 
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Figure 2: SDS-PAGE of GFPuv purified by HIC-AEX 
Lanes: 1, molecular weight ladder; 2, insoluble pellet; 3, ammonium sulfate 
precipitated proteins; 4, soluble extract; 5, HIC flow through; 6, HIC bound proteins; 
7, after dialysis; 8, AEX flow through; 9, small AEX elution peak; 10, GFPuv peak. 
Lanes 5, 8, and 9 were prepared from TCA/DOC precipitated proteins 
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Proteins recovered all steps of the purification are illustrated in Figure 2 and the accompanying 
process data is given in Table 1. This scheme purified over-expressed GFPuv by 3.2-fold using 
non-affinity based matrices, noting that this is out of a maximum purification fold of 4.8. GFPuv 
yield attained from the column steps was 77% and was purified to approximately 66% purity, 
determined by gel densitometry. Calculation of the process yield did not consider the HIC bound 
proteins that were dialyzed but not ultimately loaded on the Q column, as only 5 ml were used 
for the final column step; however when accounting for actual GFP loss during dialysis, overall 
yield was 55%. While our aim was not centered on yield optimization, other dialysis methods 
could have been mitigated loss between column steps. Minor flow through in the HIC step and 
the GFPuv fraction pooling strategy attribute to much of the detriment to yield during 
chromatography, but overall it is comparable to multi-step non-affinity schemes reported 
elsewhere (Follman and Fahrner 2004). 
Purification of a target protein to homogeneity using this or similar scheme, without further fine-
tuning of operational or column conditions, would likely necessitate a third polishing column 
step. This presents an opportunity to improve efficiency using an approach that uses proteomic 
tools to suggest rational genetic modifications specifically advantageous for downstream 
processing. Thirteen proteins that co-eluted with GFPuv are presented in Table 2.  
Several of the identified proteins in the final pool were present in only small amounts. Included 
in this group are TCA cycle enzymes: aconitase B (acnB) the beta subunit of ADP-forming 
succinyl-coA ligase (sucC) and citrate synthase (gltA). Mutants lacking sucC and gltA are 
undesirable for biotechnology applications since they have been shown to produce elevated 
acetate levels (Lee, Goel et al. 1994; Li, Ho et al. 2006). Enzymes involved in amino acid 
biosynthesis are tetrahydrodipicolinate N-succinyltransferase (dapD) and cysteine synthase A 
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(cysK). Others include the essential class I isoleucyl-tRNA synthetase (ileS);(Antonio, McFerran 
et al. 2002) the T subunit of the glycine cleavage complex aminomethyltransferase (gcvT); 
transaldolase B (talB), which has been previously purified by ammonium sulfate precipitation 
and AEX;(Sprenger, Schorken et al. 1995) alkyl hydroperoxide reductase subunit C (ahpC); 
phosphoheptose isomerase (gmhA); and elongation factor Ts (tsf), which associates with the EF-
Tu-GDP complex at the ribosome and induces exchange of GDP to GTP.(Miller and Weissbac.H 
1970) Nonessential proteins in this group total less than 8% of the final pool by densitometry; 
and thus knockout of such individual genes, if not detrimental to the cell, would not be expected 
to significantly enhance purification efficiency. 
Other gene products opportune for deletion are those that burden the purification scheme but do 
not ultimately co-purify with the protein of interest. For column steps, for example, these 
proteins hinder target binding capacity without necessarily reducing final purity. Indeed, protein 
bands of interest were identified regardless of where they appeared in the process. Here, 
clarification with ammonium sulfate prevented some such proteins from burdening column steps. 
Outer membrane porin OmpF (~37 kDa) contributed significantly to the insoluble and soluble 
protein fractions, but was preferentially removed with ammonium sulfate, shown in Figure 1 and 
lane 3 of Fig. 2. Although it was reported that mutants lacking OmpF have reduced susceptibility 
to -lactam and tetracycline antibiotics, this was found at low concentrations (1-2 g/mL 
ampicillin) relevant to natural environments and not at those used to provide selection pressure 
(50-100 g/mL) (Duval, Nicoloff et al. 2009). Based on this case, knockout of ompF may be 
desirable to ease the metabolic burden on a host expressing recombinant proteins at high levels. 
While knockout of ompF could be advantageous, its dramatic precipitation relative to the target 
prior to any column step nevertheless lends credence to use of this scheme that dissipates the 
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burden of host protein removal over multiple non-affinity-based steps. This is also neatly 
illustrated by the separation of elongation factor Tu (EF-Tu, tufA) and chaperonin GroEL (groL) 
over both column operations. Shown in lanes 4-7 and 9 of Figure 2 are prominent bands of 43 
kDa and 57 kDa, associated with EF-Tu and GroEL respectively, which depicts their removal in 
both the flow through during HIC and elution in a peak distinct from the target during AEX (EF-
Tu/GroEL were confirmed by PMF; corresponding scores 92/83, e-values 3.4e-4/2.6e-3, 10/9 
peptides, 26%/18% sequence coverage). Their ultimate binding to the AEX column is 
unfortunate given the importance of GroEL and EF-Tu to protein folding and translation, 
respectively. Mutants deficient of groL are not viable and those deficient in tufA have a slow-
growth phenotype in complex media (Fayet, Ziegelhoffer et al. 1989; Zuurmond, Rundlof et al. 
1999). 
A combined proteomic and host cell engineering approach can offer significant gains in 
downstream processing efficiency by genetically removing the most burdensome co-eluting 
proteins. Gene pckA encodes phosphoenolpyruvate carboxykinase (PEPCK) and aminoacyl-
histidine dipeptidase (PepD) were the prominent contaminants, accounting for about 15% of co-
eluting proteins by mass. PepD is a metallo-dipeptidase that acts on a broad spectrum of 
substrates with unblocked N termini, including unusual dipeptides like L-carnosine (Miller and 
Schwartz 1978; Schroeder, Henrich et al. 1994). It has been hypothesized that a significant 
portion of PepD activity lies outside the cytoplasmic membrane, perhaps aiding the degradation 
of lengthy peptides for transport into the cell (Henrich, Monnerjahn et al. 1990). E. coli posses 
many peptidases, however, and pepD-deficient mutants can still utilize a diverse array of 
peptides (Miller and Schwartz 1978). PEPCK is a gluconeogenic enzyme that requires divalent 
cation(s) to catalyze the reversible decarboxylation and mononucleotide-dependent 
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phosphorylation of oxaloacetate, yielding phosphoenolpyruvate (PEP), CO2, and the 
corresponding nucleoside diphosphate (Utter and Kolenbrander 1972). PEPCK and PEP 
carboxylase, which catalyzes the reverse reaction, act at a critical node of carbon metabolism by 
maintaining the PEP:oxaloacetate ratio and concentrations of TCA intermediates (Sauer and 
Eikmanns 2005). PEP carboxylase exclusively catalyzes the anaplerotic reaction from C3 
metabolites in E. coli. Inactivation of pckA has been shown by Yang et al. to cause a reciprocal 
drop in PEP carboxylation and increased carbon flux through glyoxylate shunt, replenishing 
TCA cycle intermediates, namely oxaloacetate (Yang, Hua et al. 2003). It was also noted that 
this flux pattern was similarly found in the low acetate producer BL21,(Noronha, Yeh et al. 
2000) and further that pckA mutants showed significantly increased biomass yields and reduced 
CO2 evolution rates compared with wild-type E. coli during slow growth in glucose-limited 
media (Yang, Hua et al. 2003). These reports lend credence to a plausible use for ∆pckA strains 
in biotechnology applications.  
Given the strong presence of PEPCK and PepD in the co-eluting pool and the prior findings 
discussed, there are grounds for further development of a ∆pckA ∆pepD strain intrinsically 
advantageous for purification of select recombinant products via HIC-AEX schemes. 
 
Purification of arg6-GFPuv 
As before, little process optimization was carried out for the CEX step. It was intended to use the 
minimal operating pH that ensured sufficient retention of the target while the vast majority of E. 
coli host proteins, carrying a net negative charge, flowed through. Analysis of co-eluting proteins 
could thus be applicable to a variety of eluting strategies. Soluble lysates were prepared in a 
loading buffer of 50 mM MES and adjusted to pH 5.7, the pI of untagged GFPuv. Lysozyme was 
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not used in the sample preparation, anticipating its dominating presence in the CEX eluate. Five 
CV of sample was passed through a 1 mL HiTrap SP FF column. Fluorescence detected arg6-
GFPuv breakthrough of 8%; whereas lysate containing untagged GFPuv in the same conditions 
showed no target retention (not shown). Proteins were eluted with a linear NaCl gradient to 1 M. 
No proteins were recovered in the subsequent step elution to 2 M. 
Proteins were sampled at each step in the process and fractionated by SDS-PAGE and presented 
in Figure 3, with corresponding purification data shown in Table 1. The target was purified to 
about 50% purity, a 2.6-fold refinement, at 90% yield. Note that while this CEX scheme did not 
outperform the HIC-AEX scheme, the column step was expectedly superior to either individual 
step in the prior strategy due to the endowed localized charge. The purity achieved may see 
underwhelming in comparison to other studies where multiple steps were used,(Sassenfeld and 
Brewer 1984) but the process yield compares very favorably to previous successful uses of this 
method (Kweon, Lee et al. 2002). However, it is noted again this purification was intentionally 
not optimized for maximum performance. Though it was troubling to find a high amount of 
insoluble target expression (lane 2), even more so than in the un-tagged strain cultured 
identically in spite of evidence that polyarginine tags improve solubility (Kato, Maki et al. 2007). 
This effect could possibly have been mitigated with the addition of NaCl during resuspension 
(Fuchs and Raines 2005). The focus, however, was specifically on soluble host proteins that 
challenged the column step. Note that OmpF, in this case again highly expressed, flowed through 
the column under the given conditions (lane 4). Also found in the flow through are the 
characteristic bands of RNA polymerase / ’ subunits (~155 kDa). 
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Figure 3: SDS-PAGE of arg6-GFPuv purification by CEX. 
Lanes: 1, molecular weight ladder; 2, insoluble pellet; 3, soluble extract; 4, flow through; 
5, wash fraction; 6, first eluting peak; 7, arg6-GFPuv peak 
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Table 3: Proteins co-eluting with arg6-GFPuv during purification by CEX 
 
 
 
Gene Protein Name 
Protein Mass 
(Da) 
Protein pI 
UniProtKB Accession 
No. 
putA Bifunctional protein putA 143725 5.69 P09546 
lepA Elongation factor 4 66528 5.40 P60785 
lysS Lysyl-tRNA synthetase 57567 5.11 P0A8N3 
tig Trigger factor 48163 4.83 P0A850 
iscS Cysteine desulfurase 45061 5.94 P0A6B7 
sucC Succinyl-CoA ligase [ADP-forming] subunit beta 41367 5.37 P0A836 
rplC 50S ribosomal protein L3 22230 9.91 P60438 
rplF 50S ribosomal protein L6 18892 9.71 P0AG55 
rplI 50S ribosomal protein L9 15759 6.17 P0A7R1 
yifE UPF0438 protein yifE 13125 6.10 P0ADN2 
rplY 50S ribosomal protein L25 10687 9.60 P68919 
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Eleven proteins confirmed to co-elute with arg6-GFPuv are presented in Table 3. Some lesser 
contaminating proteins are lysyl-tRNA synthetase (lysS), bifunctional protein PutA (putA), and 
UPF0438 protein (yifE). Cysteine desulfurase (iscS) acts in iron-sulfur clusters after assembly 
with scaffold homolog IscU and possibly has a role in regulation of genes associated with 
pyrimidine metabolism(Mihara, Hidese et al. 2008). Mutants deficient in iscS have been 
characterized to have a slow growth phenotype (Schwartz, Djaman et al. 2000). 
Trigger factor (tig) is a well-studied ribosome-associated chaperone, binding to nascent peptides 
at the exit site, exhibits peptidyl-prolyl cis/trans isomerase activity, and play a role in Sec- and 
SRP-dependent protein export(Baneyx and Mujacic 2004). While ∆tig strains have no obvious 
growth phenotype or increased protein aggregation, it must be compensated by the DnaK/J and 
GroEL/S systems;(Deuerling, Schulze-Specking et al. 1999; Teter, Houry et al. 1999) therefore 
tig mutants are ill-suited for biotech applications that utilize over-expression of recombinant 
proteins. For further detail, readers are encouraged to see these reviews (Baneyx and Mujacic 
2004; Hoffmann, Bukau et al. 2010). 
Elongation factor 4 (lepA) is a translational GTPase with an apparent ability to catalyze reverse 
translocation in vitro(Qin, Polacek et al. 2006) and was thought to play a role in translation 
fidelity. Recent evidence, however, not only confirms prior reports that mutants lacking lepA 
have no deleterious effect on growth rate(Dibb and Wolfe 1986), but also suggests that its gene 
product does not contribute to translation fidelity (Shoji, Janssen et al. 2010). 
Four out of the thirteen identified contaminants are 50S ribosomal proteins L3 (rplC), L6 (rplF), 
L9 (rplI), and the overwhelmingly present L25 (rplY). Excluding GFPuv, L25 accounted for 
about a third of bound protein by densitometry. The former three are essential for E. coli cell 
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viability,(Schulze and Nierhaus 1982; Herbst, Nichols et al. 1994; Brodersen and Nissen 2005) 
though L25 deserves further consideration. It was the first discovered representative the CTC 
(catabolite controlled) family in 1972(Horne and Erdmann 1972). Proteins of this class are 
associated with stress conditions and characteristically bind to the designated loop E region of 5S 
rRNA in the 50S subunit,(Douthwaite, Garrett et al. 1979; Gongadze, Meshcheryakov et al. 
1999; Harms, Schluenzen et al. 2001) a domain strictly conserved in bacteria(Szymanski, 
Barciszewska et al. 2002) and distinctive for consecutive non-Watson-Crick base pairs.  Indeed, 
evidence has shown that all CTC proteins possess a domain, homologous to L25, responsible for 
5S binding at this site, their only known target for interaction (Fedorov, Meshcheryakov et al. 
2001; Gongadze, Korepanov et al. 2005). Given the wealth of biochemical, interaction, and 
structural studies, questions remain concerning their cellular function unique in bacteria and role 
in translation. L25, like others of the CTC class, is thought of as an evolutionary feature of 
translation exclusive to bacteria, and is hypothesized to have a possible role in ribosome 
recycling (Korepanov, Gongadze et al. 2007). In E. coli, cells survive knockout of L25 but 
exhibit inhibited growth and protein translation which could be recovered by L25 expression 
from plasmid;(Korepanov, Gongadze et al. 2007) nevertheless such a strategy is unsuitable for 
biotechnology applications.  
Sequence alignment has revealed surprisingly low sequence homology among 300 CTC proteins 
given the nature in which they associate with the ribosome. Only five residues are strictly 
conserved (Stoldt, Wohnert et al. 1998) In L25, these are R9, R21, Y31, H88 and D90. It has 
been shown that these amino acids interact primarily with the phosphoribose backbone via 
hydrogen bonding, inaccessible to the solvent (Stoldt, Wohnert et al. 1999; Lu and Steitz 2000; 
Fedorov, Meshcheryakov et al. 2001). Subsequent mutation experiments with TL5, an L25 
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homologue in Thermus thermophilus, found that alanine substitution of non-conserved hydrogen 
bond-forming residues does not significantly attenuate 5S rRNA complex formation (Gongadze, 
Korepanov et al. 2005; Korobeinikova, Gongadze et al. 2008). This is attributed to their solvent 
accessibility. While these substitutions may exact an entropic cost, it is compensated by new 
hydrogen bonding with the solvent; whereas with any single conserved, inaccessible residue, and 
such mutation results in complex dissolution (Gongadze, Korepanov et al. 2005). 
In contrast with affinity techniques, CEX interaction is based on electrostatic charge. 
Modifications of proteins that prompt retention loss are thus not likely limited to one or two 
select residues, especially with large proteins. E. coli L25 however, is a uniquely good candidate 
for residue modification due to its small size and few occasions with consecutive positively 
charged residues. In yet unpublished results, our group and colleagues have used this approach to 
modify catabolite repressor protein (CAP) and triosephosphate isomerase (TPI) to eliminate 
retention on immobilized metal columns. A similar approach by Humphreys et al. introduced 
surface mutations and fused six aspartic acid residues to the C-terminus of PhoS/PstS protein, 
substantially shifting its ‘functional pI’ to prevent its co-elution with a recombinant Fab’ 
fragment (Humphreys, Heywood et al. 2004). Based on these and prior findings discussed, it is 
hypothesized that an altered L25 with substitutions to some of its non-conserved lysine and 
arginine residues, particularly consecutive arginines 18 and 19 and/or lysines 68, 71 and 73, 
would have vastly reduced affinity for CEX matrices. And use of a host strain deficient in lepA 
and with altered L25 could have significant, intrinsic advantages for CEX separation of 
polyarginine tagged proteins. 
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Conclusions 
Reported in this study are the preliminary efforts to integrate rational upstream host design and 
downstream efficiency using proteomic tools to evaluate co-eluting host proteins that most 
significantly burden two non-affinity based processes. Phosphoenolpyruvate carboxykinase and 
peptidase D dominated non-target binding after HIC-AEX, accounting for almost half of the host 
protein that co-eluted with GFPuv. Previous inactivation of pckA and pepD has not revealed 
evidence for growth or expression-associated problems that concern biotechnology applications. 
L25 may alternatively be modified to lessen or eliminate its column burden to significantly 
improve target purity. This analysis serves an expressed need for process integration based on 
improved knowledge on physicochemical properties of relevant host proteins, in an effort to rival 
efficiency of affinity separation methods with inexpensive resins.  As this knowledge expands 
with purification of other model proteins, host strains more robust to contamination can be 
developed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
